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FACTORS AFFECTING THE RENAI EXCRETION OF ORGANIC BASES
CHAPTER I •
INTRODUCTION
The hiological actions of organic bases have long 
been recognized and have been the subject of many investi­
gations. However, investigators focused relatively little 
attention on the mechanisms involved in the excretion of 
these compounds. In 194-8 Sperber showed that N^-methyl- 
nicotinamide (NMN) was excreted by filtration and tubular 
secretion. Since that time, the excretory processes for 
many specific organic bases have been studied; however, 
the specific factors affecting their excretion are far 
from being understood.
Organic bases are classified as either strong or 
weak bases. In the physiological pH ranges of plasma and 
urine, strong bases are totally dissociated while weak 
bases exist in both the dissociated and undissociated forms. 
In the work to be presented here, attention was focused on 
a) the excretion relationships of strong and weak organic 
bases, and b) the excretion relationships of organic cations 
and inorganic cations, particularly potassium.
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In the intact animal, using the classical clear­
ance technique (Smith 1951, 1956), substances are shown 
to be excreted by glomerular filtration alone, by filtra­
tion as well as tubular secretion, or by filtration to­
gether with partial tubular reabsorption. The evidence 
for tubular reabsorption or tubular secretion of a sub­
stance is obtained by comparison studies with a compound 
such as inulin or creatinine that has been shown to be 
neither secreted nor reabsorbed by tubular cells. Tubular 
secretion is shown to occur if the clearance of the sub­
stance (urinary concentration of the substance times the 
urinary volume divided by the plasma concentration) is 
greater than the simultaneously measured clearance of 
inulin or creatinine. Tubular reabsorption is shown to 
occur if the clearance of the substance is less than the 
simultaneously measured creatinine or inulin clearance.
The clearance of inulin or creatinine is taken as a mea­
sure of the glomerular filtration rate of the kidney.
Tubular reabsorption or secretion of a substance 
may occur by passive diffusion and/or by an active trans­
port mechanism operating within the tubular cells.
A system which transports a substance against a 
concentration gradient, either from tubular lumen to peri­
tubular fluid, or from peritubular fluid to the tubular 
lumen, and which utilizes energy derived from cellular me­
tabolism is defined as an active transport system (Tag­
3
gart, 1958). An active transport mechanism exhibits a) 
saturation of the mechanism and a fixed maximal rate of 
transfer (Wilbrandt, 1954), and b) competitive or non­
competitive inhibition. Two compounds are believed to be 
transported by a "common" transport system when a single 
non-competitive inhibitor is shown to block the transport 
of both substances, and when the clearance of one compound 
is inhibited by the simultaneous infusion of a second com­
pound.
There is conclusive evidence that strong organic 
bases are excreted by filtration and tubular secretion as 
shown in Table 1.
Furthermore, evidence has been presented which sug­
gests that the tubular secretion of at least certain of 
these bases is by an active transport mechanism. The 
strongest evidence in support of active transport has been 
shown as a result of the mutual competitive inhibition in 
the tubular excretion of one organic base on another, and 
in the inhibition of tubular excretion by metabolic inhi­
bitors . This evidence was secured in both In vivo and in 
vitro studies.
Kandel and Peters (1957) showed that Darstine pro­
duced inhibition of the tubular secretion of NMN in dogs. 
Further, they showed an inhibition of Darstine excretion 
when high NMN loads were simultaneously infused.
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TABLE 1
TUBULAR SECRETION SHOWN FOR CERTAIN ORGANIC BASES 
IN THE MAMMALIAN OR AVIAN KIDNEY
Base Animal Investigators
N^-methyl-nicotinamide (NMN) Chicken Sperber (1948)
Guanidine Chicken Sperber (1948)
Piperidine Chicken Sperber (1948)
Tolazoline (Priscoline) Dog Orloff et al., (1953)
N-methyl-nicotinamide Dog Beyer et al., (1948)
T etraethylammonium 
chloride (TEA) Dog Rennick et al. , (1954)
Mepiperphenidol (Darstine) Dog Beyer et al.. (1953)
Thiamine Chicken Rennick (1958)
Choline Chicken Rennick (1958)
Hexaméthonium Chicken Rennick (1958)
Sperber (1948) demonstrated that tubular secretion 
of piperidine in the chicken vas inhibited by the adminis­
tration of NMN. Other inhibitory relations have been shown 
in this species: Darstine inhibited the excretion of NMN;
Priscoline inhibited NMN (Voile et 1959); Priscoline
inhibited the excretion of histamine (Lindahl and Sperber,
1958), and thiamine depressed the excretion of choline 
(Rennick, 1958). Furthermore, both TEA and choline have 
been shown to inhibit NMN tubular excretion, while NMN 
has been shown to inhibit TEA excretion (Green et al..
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1959; Voile et al., 1959).
The ^  vitro technique used in studying renal tu­
bular transport (Cross and Taggart, 1950) involves the mea­
surement of the accumulation of the base in kidney slices 
following incubation of the slice in the Warburg apparatus. 
The accumulation in the slice is related to that concen­
tration remaining in the medium after incubation, and is ex­
pressed as the slice/medium ratio (8/M ratio). An S/M ratio 
greater than one is considered indicative of active trans­
port, i.e., movement from a lesser concentration to a greater 
concentration.
TEA (Parah and Rennick, 1956), Darstine (LeSher and 
Shidemen, 1956) and NMN (Parah et ̂ ., 1959) have been 
shown to accumulate in renal slices with 8/M ratios exceed­
ing 7. Priscoline, guanidine, and piperidine, when added 
simultaneously with TEA in the suspending medium, inhibited 
the accumulation of TEA in the slice (Parah et al., 1957)• 
Similarly, Priscoline, Darstine, choline, and guanidine in­
hibited the uptake of NMN in renal slices (Parah et al.,
1959).
2, 4-dinitrophenol (DNP), an inhibitor of cellular 
metabolism (Cross et , 19^9) has been shown to depress 
the tubular transport of TEA in the dog (Rennick and Parah, 
1956), and to depress the accumulation of TEA (Parah and 
Rennick, 1956), NMN (Parah et al., 1959) and Darstine
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(LeSher and Shldeman, 1956) In renal slices.
These findings strongly suggest not only that strong 
bases are excreted by active tubular transport but also that 
they share, at least in some part, a common transport sys­
tem.
The excretion of weak: bases has been attributed pri­
marily to filtration and tubular secretion or reabsorption 
as a result of passive diffusion of the undissociated base 
(Milne et al., 1958). The undissociated form of a substance 
penetrates cell membranes more rapidly than the ionized form 
(Ousterhout, 1925; Jacobs, 1940). The flux direction, i.e., 
secretion or reabsorption, for this undissociated molecule 
is dependent upon the pH gradient between urine and plasma. 
When the urine is alkaline, more of the base exists in the 
urine in the undissociated form than in the plasma and thus 
diffuses from tubule to plasma. The result is net tubular 
reabsorption of the base. When the urine is acid, the con­
centration gradient for the undissociated form of the base 
is from plasma to urine. This un-ionized form diffuses in­
to the tubular lumen, where it dissociates into the ionic 
form as a result of the more acidic fluid. Thus the base is 
trapped and net tubular secretion results.
Table 2 is adapted from Milne (1958). The organic 
bases listed in this table have been shown to be reabsorbed 




WEAK BASES BELIEVED TO BE EXCRETED BY 
FILTRATION AND NON-IONIC DIFFUSION
Base Animal Investigator
Nicotine Man Haag and Larsons (1942)
Quinine Man Haag et al^, (1943)
Quinocrine (Atabrine) Man Jailer et al., (1947)
Chloroquine (Aralen) Man Jailer et al., (1947)
Ammonia Rat Ferguson (1951)
Ammonia Dog Orloff and Berliner (1956)
Procaine Dog and 
rabbit Terp (1951)
Mecamylamine (Inversine) Dog Baer et al., (1956) 
Scribner et al., (1959)
Implicit in the concept for non-ionic diffusion is 
that the direct movement of the substance from peritubular 
fluid into the tubular lumen, or from the tubular lumen in­
to the peritubular fluid does not require energy from the 
cell, and that the movement of the substance is neither 
competitively nor non-competitively inhibited.
There is little direct evidence that active tubular 
transport of weak bases does or does not occur. In the 
aglomerular fish, however, tetraethylamine oxide was shown
8
to be actively secreted Forster (et al., 1958). The excre­
tion of NMN in the chicken was shown to be inhibited rapid­
ly when mecamylamine, quinine, or quinacrine were infused 
simultaneously (Voile et aJ.., I96O; and Voile and Peters,
1959). However, a decisive active tubular transport in 
this species for the three weak bases could not be demon­
strated.
The inorganic, monovalent cations, sodium and po­
tassium, have been shown to be transported actively by the 
tubular cells of the kidney. The sodium retaining ability 
of the mammalian kidney is well documented (Smith, 1955,
1951).
Independent investigations by Mudge et al., (19^8), 
and Berliner and Kennedy (1948) presented evidence that 
potassium is excreted by glomerular filtration and tubular 
secretion. Berliner hypothesized that the secretion of po­
tassium was the result of an ion exchange involving potas­
sium and sodium.
The secretion of potassium shows certain features 
associated with an active transport mechanism. It was 
shown to be competitively inhibited by the hydrogen ion 
(Berliner et al̂ ., 1951) and non-competitively inhibited 
by mercurial diuretics (Mudge et al., 1950).
Inorganic and organic cation tubular excretion re­
lationships have been demonstrated for certain bases.
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Kandel (1956) showed that, after a period of forced 
feeding of KCl in the dog, the simultaneous infusion of KCl 
with Darstine or NMN resulted in a reduction of the renal 
tubular excretion of these bases. A depression of potassium 
excretion when NMN, Darstine, and Priscoline were infused 
was shown in Diamox treated dogs (Kandel and Domer, 1957)•
After a period of forced-feeding of Priscoline, NMN 
or Darstine to dogs, inhibition of potassium secretion oc­
curred when these bases were simultaneously infused with po­
tassium (Domer, i960). Solomon and co-workers, (i960) pre­
sented evidence of increased reabsorption of sodium and po­
tassium when choline was infused in the dog.
In summary, the evidence presented appears to indi­
cate a) strong organic bases are excreted by filtration and 
active tubular excretion; b) some phase of the tubular move­
ment of strong bases involves a common transport mechanism; 
c) weak bases are excreted by filtration and non-ionic dif­
fusion; d) strong bases and the inorganic cations, sodium 
and potassium, may share a common base-excreting mechanism.
The hypothesis used in investigating organic and 
inorganic base relationships for this work resulted from 
preliminary studies in this laboratory on the excretion re­
lationship of potassium and a weak base, mecamylamine.
Baer and co-workers, (1956) showed that the excre­
tion of mecamylamine was profoundly influenced by the pH of
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the urine; tubular secretion occurred as a result of a 
highly acidic urine, and reabsorption occurred in a highly 
alkaline urine. When urinary pH was maintained constant, 
secretion or reabsorption was not inhibited by probenecid 
(Benemid) or para-amino hippurate (PAH) . No maximal rate 
of transfer occurred when plasma concentrations of meca­
mylamine were increased.
These investigators suggested that, although the 
results could be interpreted as excretion by passive dif­
fusion, the secretion and reabsorption of mecamylamine 
could- also be by an active bi-directional transport system, 
with the direction governed indirectly by the pH of the tu­
bular urine. Lotspeich (1958) further proposed that meca­
mylamine may participate in a cation exchange transport 
system.
Subsequent studies on mecamylamine excretion by 
Scribner et al., (1959) confirmed the results presented by 
Baer. These workers, however, concluded that mecamylamine 
reabsorption and secretion was solely by non-ionic diffusion.
This laboratory corroborated the results of the pre­
vious workers but further showed that there was a definite 
inverse relationship between mecamylamine excretion and po­
tassium excretion when the urine pH was changed from acidic 
to basic. This evidence suggested that mecamylamine could 
participate in a cation exchange mechanism.
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The working hypothesis for this study, therefore, 
was that the tubular secretion of mecamylamine occurred pri­
marily by a pH-dependent transport system presumably compet­
ing with potassium for cation exchange. As the excretion of 
Darstine, a strong base, had been shown to be inhibited by 
potassium administration, it was of interest to investigate 
the excretion of this compound under similar conditions 
used to study the excretion of mecamylamine.
The experiments in this study were designed to 
answer several specific questions.
1. Is the tubular excretion of mecamylamine related 
to a cation exchange transport system?
2. Is potassium the cation involved in the exchange
system?
3. Is the tubular excretion of Darstine (a strong 
base) similar to mecamylamine (a weak base)?
4. Where in the tubule does the secretion and re­
absorption of mecamylamine occur, and where does the secre­
tion of Darstine occur?
5. Does the tubular excretion of mecamylamine occur 
by an active transport system?
Clearance studies were performed to answer the first 
three questions.
The generally accepted transport system for cation 
exchange in the renal tubules involves sodium reabsorption
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with the potassium and hydrogen Ion competing for secretion 
(Pitts, 1958). The hydrogen Ion secretion Is dependent upon 
the hydrogen Ion concentration In plasma and the secretion 
Is competitively Inhibited by Increased plasma potassium 
concentration.
The tubular excretion of potassium Is Inversely re­
lated to plasma hydrogen Ion concentration. Increased ex­
cretion of potassium occurs with decreased hydrogen Ion con­
centration and decreased excretion occurs with Increased 
hydrogen Ion concentration.
Therefore, to determine If mecamylamine participates 
In the cation exchange system, as well as to evaluate meca­
mylamine excretion by "non-lonlc" diffusion, the excretion 
of the drug was studied not only at normal systemic pH 
valves, but also when plasma hydrogen Ion concentrations 
were varied by the Induction of systemic acidosis or alka­
losis, with low or high urinary flow rates. Potassium ex­
cretion was routinely Investigated throughout the experi­
ments .
Furthermore, In order to evaluate If potassium Is 
the cation Involved In the exchange system, the effects of 
the acute administration of mecamylamine on potassium f jre- 
tlon, and the effects of the acute administration of mecamy­
lamine on potassium excretion were studied.
In order to determine If the excretion of Darstine 
Is similar to the excretion of mecamylamine, Darstine and
13
potassium tubular excretion were investigated with the same 
experimental procedures used for mecamylamine studies.
Sodium excretion was studied in five of the mecamy­
lamine experiments and in three of the Darstine experiments.
Mecamylamine is a secondary amine and a ganglionic 
blocking drug (Stone et al., 1956); Darstine is a quaternary 
ammonium compound and an anticholinergic drug (Beyer et al., 
1953)* Mecamylamine is used clinically as a hypotensive drug; 
Darstine, although used clinically as a spasmolytic drug, has 
been shown to have hypotensive effects with high plasma con­
centrations. Thus, as either of these compounds could dras­
tically change systemic blood pressure and thereby alter kid­
ney function, it was important to monitor blood pressure 
throughout each experiment.
A technique for localization of renal tubular ac­
tivity by stop-flow analysis in the intact animal was intro­
duced in 1957 by Malvin and Wilde. Tubular secretion of TEA 
has been shown to occur in the proximal tubule of the dog 
(Rennick et a^., 1959). The stop-flow analysis, therefore, 
was used to determine the site in the nephron of tubular se­
cretion and reabsorption of mecamylamine, and the tubular 
secretion of Darstine.
In order to evaluate if the tubular secretion of 
mecamylamine is by an active transport system the accumula­
tion of the compound in rat kidney slices was studied.
CHAPTER II 
EXPERIMENTAL PROCEDURES AND METHODS
Three experimental procedures were used in this re­
search: The standard clearance technique (Jollifee and
Smith, 1931)» the stop flow analysis (Malvin et al., 1957)> 
and the ^  vitro accumulation studies in rat kidney slices 
(Cross and Taggart, 1950).
Standard Clearance Technique
The utilization of this technique enabled the ex­
cretion studies to be evaluated in the intact, unoperated 
animal.
Renal clearances for all experiments were performed 
on post-absorptive mongrel female dogs weighing between 
18-25 kg. Each animal was hydrated orally with 500 ml. tap 
water. Following hydration, if the animal was to be anes­
thetized, 30 mg/kg. of sodium pentobarbital was administered 
intravenously.
Following the administration of the anesthetic, the 
brachial vein was catheterized with a No. 90 polyethylene 
catheter. A priming solution of creatinine, mecamylamine 
or Darstine was given intravenously to establish the plasma
14
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levels of these substances. In order to maintain the plasma 
levels constant an Infusion solution vas delivered at the 
rate of 5 ml/mln. by a Slgmamotor constant Infusion pump. 
Equilibration periods of 40-120 minutes were allowed from 
the beginning of the Infusion to the beginning of the first 
collection period.
During this equilibration period, the femoral artery 
was catheterized with No. 90 polyethylene tubing. Clotting 
In the tubing was prevented by periodic Injections of heparin. 
An Indwelling Foley catheter was Inserted Into the bladder 
for urine collections.
Experimental procedure varied for each of the experi­
ments. Each urinary collection period was timed. Three 
control periods were followed by three experimental periods, 
and In many experiments, three additional experimental urine 
collection periods were taken. The rate of urine flow at 
the beginning of each experiment determined the length of 
the collection periods. At high flow rates timed periods 
were ten minutes In duration, at low flow rates fifteen 
minutes In duration.
Arterial blood samples were taken at the mld-polnt 
In each timed urine collection period. Blood samples were 
collected under oil, and allowed to stand thirty minutes at 
room temperature for separation of serum. The samples were 
then centrifuged and the serum was transferred under oil to 
clean tubes.
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Urine samples were also collected under oil Into 
graduated cylinders. In those experiments with very low 
urine flows, the bladder was washed out with 10 ml. of dis­
tilled water and room air. The bladder was emptied by man­
ual suprapubic pressure.
The exogenous creatinine clearance was used as the 
measure of glomerular filtration rate. Creatinine concen­
trations were determined by the methods of Bonsnes and 
Tassosky (1945). The method consists of adding alkaline 
picrate and reading samples In a colorimeter at 525 mp.
Mecamylamine concentration In plasma and urine was 
determined by the method of Brodle and Undenfrlend (1945). 
The method Includes extraction of the base with ethylene 
dlchlorlde at an alkaline pH and the subsequent formation 
of a highly colored acid salt with methyl orange. The con­
centration of the base Is determined Indirectly through 
measurement of the sulfonic acid salt photometrically. Re­
coveries of added base average 95 per cent of theoretical, 
with total quantities as low as five micrograms.
Darstine concentrations In urine and plasma were 
determined by the method of Tllllson et al., (1954). This 
method Is similar to that described for mecamylamine. In 
that the base Is extracted Into ethylene dlchlorlde at an 
alkaline pH and the subsequent formation with methyl orange 
of a highly colored acid salt acidified with boric acid.
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The concentration of the base is determined indirectly 
through measurement of the sulfonic acid salt photometric­
ally.
Plasma and urine and Na^ concentrations were 
analyzed with the Baird flame photometer (internal standard 
method).
The clearance of para-aminohippurate (PAH) was used 
as a measure of renal plasma flow. PAH concentrations in 
urine and plasma were determined by the method of Smith et 
al., (1945).
The pH of plasma and urine was determined under oil 
with a Beckman Model 'jS Expanded Scale pH meter using a 
glass electrode (limit of accuracy 0.02 pH units), at room 
temperature and corrected to 37° C*
Total carbon dioxide content of plasma and urine 
was measured on a Van Slyke Magne-Matic apparatus using the 
technique of Peters and Van Slyke (1924). Plasma and urine 
bicarbonate concentration, partial pressure of carbon diox­
ide, and carbonic acid concentration were calculated from 
the Henderson-Hasselbalch equation.
Respiratory alkalosis was induced by hyperventila­
tion with a Harvard Apparatus respiration pump. Model IO63. 
The rates of hyperventilation varied, and are recorded in 
appropriate tables in Chapter III.
Respiratory acidosis was induced by supplying the
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animal vith 10 per cent COg and 90 per cent Og mixture. The 
mixture vas Inspired through a respiratory high velocity de­
mand valve; expiration vas Into room air.
Blood pressure recordings vere obtained through a 
Statham transducer connected to a 4-channel Grass polygraph. 
The transducer vas attached to the No. 90 polyethylene 
catheter Inserted Into the femoral artery.
The EGG vas recorded on the Grass polygraph simul­
taneously vlth blood pressure recordings.
Stop Plov Analysis
Of special Interest to renal physiologists vas the 
Introduction of this technique, designed to Indicate the 
site of renal tubular secretion and tubular reabsorption of 
substances In the Intact animal. This method In no vay su­
persedes or supplants the more laborious and quantitative 
method of localization of tubular activity by direct mlcro- 
puncture Introduced by A. N. Richards (1929)* Rather, It 
supplements the direct micropuncture technique, and Indeed, 
final Interpretation of results have largely rested on re­
sults derived from direct micropuncture studies of tubular 
contents.
Qualitative localization of tubular sites for se­
cretion and reabsorption Is accomplished In three vays. 
First, the tubular fluid pressure Is raised by blocitelng the 
ureter until effective filtration pressure Is exceeded.
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Glomerular filtration ceases and movement of tubular fluid 
is halted. Renal blood flow continues as was shown by the 
introduction of Na and K isotopes during stop-flow studies 
(Malvin et al., 1958)• Second, the static condition of the 
tubular fluid is maintained several minutes. This condition 
enables tubular activity along the nephrons to exaggerate 
concentrations of substances, by either more completely add­
ing or more completely removing them, than can occur during 
free-flow. Third, glomerular filtration is reinstituted by 
unclamping the ureteral catheter and tubular fluid is col­
lected in low volume consecutive samples. The urinary con­
centrations of solutes from these individual serial samples 
are plotted graphically together with free-flow urine samples 
prior to and following stop-flow samples. By comparing free­
flow concentrations with stop-flow concentrations^sites of 
tubular ability to reabsorb or secrete are inferred.
Free-flow urine is enhanced by the use of the osmotic 
diuretic, mannitol. During stop-flow, inulin is injected 
intravenously and thus entrance of new filtrate from the 
glomerulus after flow is reinstituted is indicated by the 
appearance of inulin in the tubular samples. Creatinine is 
infused with the mannitol solution, and its concentration 
in urine and plasma used as a measure of glomerular filtra­
tion rate during free-flow and is a measure of water reab­
sorption throughout the nephron in the serial samples.
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Method for Stop Plov Analysis
Fostabsorptlve mongrel dogs, male or female, weigh­
ing 10-18 kg. vere hydrated vith 500 ml. tap HgO p.o. 20 
minutes prior to administration of 30 mg/kg. sodium pento­
barbital anesthesia.
The Jugular vein vas catheterized vith No. 60 poly­
ethylene tubing vhich vas closed vith a three-vay stop cock. 
Arterial blood samples vere collected from the femoral ar­
tery vhich vas catheterized vith No. 60 polyethylene tubing. 
Coagulation vas prevented by the periodic use of heparin.
Bladder urine vas collected through a Foley catheter 
inserted into female dogs or through a No. 60 polyethylene 
catheter in male dogs.
The left ureter vas exposed by a small flank inci­
sion. The ureter vas catheterized vith No. 60 polyethylene 
tubing vhich vas passed veil up into the renal pelvis and 
then tied securely. The catheter vas secured to the edge of 
the dog table prior to collecting serial samples.
A mixture of 10 per cent mannitol, 0.9 per cent NaCl, 
0.2 per cent creatinine, 0.05 per cent PAH, and the test sub­
stance vas infused by a constant infusion pump through a 
No. 90 polyethylene catheter inserted into a brachial vein 
at 10 ml/min. A priming solution of 20 ml of 6 per cent 
creatinine, 0.25 ml. of 20 per cent PAH, and the test sub­
stance vas given simultaneously vith the start of the in­
fusion mixture.
PI
When urine flow from the left catheter had stabi­
lized at 7-10 ml/min., timed free-flow urine collections 
were taken. Midway between the collection periods, blood 
samples were obtained. At the end of the second collection 
period, the catheter in the left ureter was clamped with a 
hemostat and urine flow from that kidney halted. The cathe­
ter was clamped either 5 or 6 minutes. Two minutes prior 
to releasing the clamp, a third blood sample was taken. One 
minute before releasing the clamp, 1.0 gm. inulin in 100 ml. 
distilled water was given into the jugular vein.
Immediately upon releasing the clamp serial urine 
samples were collected. These samples, from 0.5 - 0.6 
ml/sample, were collected into 3 ml. glass tubes. The tubes 
were passed rapidly beneath the left ureteral catheter, and 
30 samples collected in a time interval of 2 1/2 - 4 minutes.
A post-occlusion timed urine collection of six minutes, 
with a mid-point blood collection, was then taken. The vol­
ume of each serial sample was accurately measured with a de­
livery pipette and this volume diluted with glass-distilled 
water to a final volume of 10 ml. Determinations of concen­
trations of substances in each sample were then made.
The methods for creatinine, PAH, and Darstine were 
those described under standard clearance technique. Na'*' 
and analyses were made on the Baird flame photometer 
(direct standard). Inulin concentration in urine and plasma
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vas determined by tbe method of Levine and Becker (1939)• 
Pre-occlusion and postocclusion urine samples and 
blood samples vere collected under oil vhere indicated in 
results. Total COg, HgCO^, HCOg and pH measurements vere 
conducted as described under clearance techniques.
Rat Kidney Slices 
The flux of a substance betveen tubular urine and 
peritubular plasma is investigated vith ̂  vivo renal stu­
dies. The specific role of the tubular cell in this move­
ment can be studied by an in vitro system, such as the kid­
ney slices.
These experiments vere carried out in a Warburg 
manometric apparatus (ïïmbreit ^  , 1957) •
Male rats veighing 300-400 gm. each vere exsan­
guinated and the kidneys vere quickly removed and chilled 
in ice-cold isotonic NaCl. Slices of 0.4 to 0.3 mm» thick­
ness vere cut vith the Stadie-Riggs micrometer (Stadie and 
Riggs, 1944) and placed in the cold NaCl solution. The 
tissue slices vere then blotted on filter paper and 200-300 
mg. of slices vere placed in a Warburg flask containing 
0.87 ml of 0.3 M NaCl, 0.2 ml of 0.1 M sodium phosphate 
buffer (pH 7.4), O.36 ml of O.3 M KCl, 0.1 ml of 0.02 M 
CaClg, 0.2 ml of appropriate molarity of Darstine or mecamy- 
1amine and brought to final volume of 2.8 ml vith distilled 
vater.
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The center well of each flask contained 0.2 ml 6N 
NaOH on fluted filter paper as COg absorber. The flasks 
were shaken at the rate of 100 cycles/min^ at 37° C. All 
flasks were flushed with Og and after a 15 minute equili­
bration period appropriate taps were closed and oxygen con­
sumption was recorded for two hours.
Immediately following the Incubation period, the 
vessels were again chilled In cracked Ice. Kidney slices 
from each vessel were quickly blotted, weighed to the 
nearest tenth of a mg. on a torsion balance stsi. transferred 
to a graduated centrifuge tube. Each tube contained 1 ml. 
of 0.1 N HCl In 15 per cent trlchloroscotlc acid. Water 
was added to a total volume of 3 ml. (Le Sher and Shldeman, 
1936). After removal of the slices from the vessels, 2 ml. 
of medium were added to 1 ml. of 15 per cent trichloroacetic 
acid for a final volume of 3 ml.
The slices were pulverized with a glass rod and 
both the medium samples and slice samples were allowed to 
stand overnight. Samples vere then centrifuged and the 
supernatant from the slices or the medium were analyzed for 
the organic base by methods previously described.
Tubular transport In renal slices Is based on a 
comparison of medium and slice concentration of a substance. 
If a substance moves by diffusion alone from the medium In­
to the slice, at the end of the Incubation period the ratio
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of the concentration of the confound in the slice to the 
concentration In the medium should be unity. If, however, 
this ratio exceeds unity. It Is Indicative of movement of 
the substance from a lover concentration to a higher con­
centration by active transport. Results are expressed as 




Results obtained from clearance studies on the ex­
cretion of mecamylamlne and Darstine are represented In 
Tables 3 - 2 1 .
The headings of the columns for these tables have 
the following definitions:
C clearance of creatinine (Cq_) , PAH (Cp^),
bicarbonate mecamylamlne (Cm ), Dar­
stine (Cj)}, potassium (Ck ), sodium 10^= ), ml/mln.
P^ plasma concentration of mecamylamlne (P»),
Darstine (Pp) mg/ml; and potassium (Pg) or 
sodium (PjfgJ, mEq/L.
CcpP% clearance of creatinine times plasma concen­
tration of mecamylamlne or Darstine equals 
amount of substance filtered, mg/mln.
Gx/Ccr clearance of substance, mecamylamlne or Dar­stine, divided by creatinine clearance.
V volume of urine, ml/mln.
TT̂  urine concentration of mecamylamlne (Ujj),
Darstine (Up), mg/ml., potassium (Ug), sodium 
(Ugĝ ), aEq/ml.
U]gV urine concentration of a substance times the
urine volume equals the amount of substance 
excreted. Includes amount of substance In 




IT̂ V-CqpF^ amount of substance excreted minus the amount
of substance filtered mg/mln. (f ) denotes 
amount of substance added to urine by tubular 
secretion over the amount filtered, (-) de­
notes amount of substance removed from urine 
as a result of tubular reabsorption.
Upjj urinary pH
Ppg plasma pH
®PAH clearance of para-amlnohlppurate, ml/mln.
U^COg total COg In urine, mM/L.
P^CQg total COg In plasma, mM/t.
Upcog partial pressure of COg In urine, mmHg.
PpCOg partial pressure of COg In plasma, mmHg.
UgQQg bicarbonate concentration In urine, mM/L.
PgQQg bicarbonate concentration In plasma, mM/L.
Gncog clearance of bicarbonate, ml/mln.
carbonic acid concentration In urine, mM/L.
PHgCOs carbonic acid concentration In plasma, mM/L.
The concentrations of mecamylamlne In plasma are re­
ported as total concentrations uncorrected for that bound to 
plasma protein (Baer et ̂ . , 1956). Thus, the amount of me­
camylamlne filtered Is the value If all of the drug were com­
pletely filterable. Corrections for plasma binding were not 
made as the direction of mecamylamlne clearance changes for 
the controls and experimental periods would be the same as 
those reported when secretion of mecamylamlne occurs. Where 
mecamylamlne Is shown to be reabsorbed, calculations to In­
clude the correction for plasma binding were executed; In
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all cases, mecamylamlne is shown to be reabsorbed as the 
data presented indicate.
Darstine has been shown to be freely filterable at 
the glomerulus (Le Sher and Shideman, 1956).
MELE 3
KVRcrs or acoes mrabolic acidosis on m cA H om m  and foeasszhi E x ca n m  during mannitol diuresis
Period lune U UmV M c*/c*
•«/•> I mg/mb I ml/mm I mg/ml aig/nin ml/min
78
-125 500 ml. 8,0 P.O.
-105 30 mg/kg. sodlam pegtobarbltgl, I.V.
- 60 Prime I: 20 ml. 6X creatiaiae + 2.5 mg/kg. meeamrlamiae
Imfegiom I; .38% creatiniae, 2.0 mg/kg/hr. meeamylamlae la 5% maaaitol, I.V. • 5 ml/mla.
10 29.93 .0019 .0569 4.9 .0228 .1120 +.0551 56.80 1.96 6.66 7.43
20 29.22 .0020 .0584 5.2 .0226 .1180 +.0596 58.76 2.01 6.66 7.43
30 28.90 .0023 .0665 5.5 .0210 .1160 +.0495 50.22 1.74 6.66 7.44
30
60 30.41 .0025 .0760 6.60 .0356 .2350 +.1590 93.98 3.09 6.40 7.34
70 30.32 .0027 .0819 6.80 .0414 .2820 +.2001 104.24 3.44 6.36 7.29
60 29.67 .0029 .0860 6.82 .0428 .2910 +.2050 100.65 3.39, 6.30 7.19
80 Add KCl to lafaiioa to give .05 N KCl
110 32.74 .0040 .1310 10.40 .0350 .3640 +.2330 91.00 2.80 5.99 7.14
120 31.02 .0046 .1427 9.62 .0384 .3690 +.2263 80.31 2.59 5.98 7.12
CO00
Period P P__ U P C U P p U U V cTOO, TOO, FOO, p m . HCO- HCo; HOOJ H,CO, H,CO, K K K ’ K
mM/L % mM/L ml/aàn mM/L m Ef/L «E^m m mt/min
1 12.53 26.33 87 40 9.84 25.33 1.90 2.69 1.20 3.95 11.75 57.58 14.582 12.06 26.80 84 40 9.47 25.60 1.92 2.59 1.20 3.95 11.70 60.84 15.403 11.48 26.75 80 40 9.01 25.55 1.94 2.47 1.20 4.00 11.70 64.35 16.08
4 10.21 20.88 110 39 6.81 19.70 2.28 3.40 1.18 3.95 13.20 87.12 22.055 9.28 18.24 107 38 5.97 17.10 2.37 3.31 1.14 3.92 13.10 B9.08 22.726 8.53 16.36 107 42 5.22 15.24 2.34 3.31 1.12 4.05 12.95 88.32 21.81
7 5.55 9.36 79 27 3.11 8.75 3.70 2.44 .61 8.10 18.00 187.20 23.118 5.74 8.31 80 26 3.27 7.70 4.09 2.47 .61 8.75 20.40 196.25 22.43
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Experiment 1
The data in Table 3 show the effects of acute me­
tabolic -acidosis on mecamylamlne and potassium excretion. 
Hydrochloric acid was added to the standard infusion after 
control values for mecamylamlne and potassium had been 
established.
This experiment vas outlined (1) to show a definite 
inverse excretion relationship betveen mecamylamlne and po­
tassium when the urine vas acidified,(2) to indicate if po­
tassium administration would inhibit the high mecamylamlne 
secretion into the acid urine.
In earlier experiments on mecamylamlne excretion, 
urinary flow rates averaged 010 -0.30 ml/min. vith isotonic 
NaCl infusion. In order to increase these urinary flows 
mannitol as an osmotic diuretic was added to the infusion 
solution in this and in other experiments vhere indicated.
The acidosis produced as the beginning of the first 
experimental periods (periods 4, 5 and 6) did cause a two­
fold increase in mecamylamlne clearance (C%). However, po­
tassium clearance (0%) increased as well (60$). As was to 
be expected from the acidosis, urinary and plasma pH de­
creased, as did total COg and urinary plasma bicarbonate. 
Bicarbonate clearance increased (CngCjg) and urinary pCOg 
and HgCOg concentrations increased.
Scribner et , (1959) had argued that if a base
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vere excreted by filtration and non-lonlo diffusion, the 
clearance of the base should Increase vlth Increased urinary 
flov, as veil as vlth a decreased urinary pH. Hovever, the 
administration of potassium chloride after metabolic acidosis 
had been established resulted In a 15-20$ depression of me­
camylamlne clearance, concomitant vlth a continued decrease 
In urinary pH and Increased urine flov rate.
Results from this experiment vere Interpreted as 
evidence that (1) vlth the 15-20$ depression of mecauqrlamlne 
clearance following ECl administration superimposed on me­
tabolic acidosis, mecamylamlne excretion vas related to a 
tubular cation exchange system,(2) potassium vas the cation 
Involved In the exchange system^(3) vlth the tvo-fold In­
crease In mecamylamlne clearance follovlng the Induction of 
metabolic acidosis, mecamylamlne secretion occurred In part 
by non-lonlc diffusion.
TABLE 4
EFFECTS OF KCl AnOHISTBAXlGN ON tBCAMTUMINB EXC8EXI0N DOBINS M&NNHOL DIURESIS
Period Time Co Pm V U m V - C c , P Cm %
min m l/m in m g/m l m g/ndn m l/m in m g/m l ing/im n m g/m in m l/m in
-125 500 ml. HoO P.O.
-105 30 mg/kg. sodium pentobarbital I.V.
— 50 Prime ]: 20 ml. 6% creatinine + 2;5 mg/kg, ■ecaaylaoiine I.V.
Infusion I: .38% creatinine, 2.0 mg/kg/hr. mecamylamine in 5% mannitol I.V, 8 5 ml/min.
1 10 35.11 .0021 .0737 6.29 .0200 .1258 +.0521 59.90 1.71 6.90 7.37
• 2 20 31.68 .0022 .0697 5.21 .0292 ,1521 +.0824 69.15 2.18 6.87 7.36
3 30 31.20 .0023 .0717 5.46 .0286 .1562 +.0845 67.89 2.15 6.79 7.39
30 Add KCl to infusion to give .05 N KCl
4 70 36.61 .0024 .0879 6.90 .0192 .1325 +.0446 55.20 1.51 6.77 7.30
5 80 37.29 .0025 .0932 8.00 .0158 .1264 +.0332 50.56 1.35 6.81 7.30
6 90 38.02 .0026 .0989 8.32 .0176 .1464 +.0475 56.32 1.48 6.82 7.19
7 100 38.03 .0027 .1027 8.66 .0170 .1472 +.0445 54.53 1.43 6.76 7.20
Period ^ T C O , Prco, ItHco; PHCOj C HCOJ PH,00, Pk "a
m M /L mm Hg m M /L m l/m in m M /L m E q/L •E q/m m m t/m in
1 13.90 23.43 62 40 11.98 22.23 3.39 1.92 1.20 3.93 10.50 66.05 16.812 15.94 23.55 75 41 13.62 22.32 3.18 2.32 1.23 3.75 12.25 63.82 17.023 15.74 23.32 86 38 13.08 22.18 3.21 2.66 1.14 3.63 12.90 70.43 19,40




The experiment reported in Table 4 was designed to 
investigate the effects of the acute administration of KCl 
on mecamylamlne excretion. Mannitol was infused to produce 
an osmotic diuresis.
The data show that mecamylamlne clearance decreased 
20^ when potassium chloride vas added to the infusion solu­
tion. This depression occurred again together vith an in­
creased urinary flov rate. Urine pH did not change signifi­
cantly. The data shov also that the urinary concentration 
of mecamylamlne (Û g) decreased and, further, that the amount 
of mecamylamlne excreted (Uĵ V) as veil as the amount of me­
camylamlne in the urine contributed by tubular secretion 
(UjjV - CcpPjj) vas depressed.
It is to be noted that, vith those substances vhich 
shov both net tubular secretion and net tubular reabsorption 
in clearance studies, a decrease in net tubular secretion 
could occur as the result of enhancement of reabsorption, or 
an inhibition of tubular secretion.
The results from this experiment vere interpreted 
as evidence that mecamylamlne could participate in the tu­
bular cation exchange system.
Period
TABLE 5
EFFECTS OF WCAMTLAMINE ADMINISTRATION ON POTASSIUM EXCRETION DURING ISOTONIC NaCl DIURESIS
Time







m l/m in m g/m l . m g/i m l/m in 1 m g/m l | m g/m in  | m g/m in m g/m l I
500 ml. HgO p.o.
30 mg/kg. sodium pentobarbital I.V.
Prime I: 20 ml. 6% creatinine + .25 ml. 20% PAH I.V.
Infusion I; .38% creatinine, .1% PAH in .9% NaCl, I.V. 8 5 ml/min.
25.78 I 2.93
20.811 I 1.93
Prime II; 2.5 mg/kg. mecamylamine in 20 ml. HgO I.V. 
Add 2.0 mg/kg/hr. mecamylamine to infusion
; 5.95 I 6.19 7.387.41
mg/ml
4 105 46.771 .0022 .1029 4 .49 .0118 .053 -.0499 24.08 .515 7 .16 7.51
5 120 42.29 .0024 .1015 3 .70 .0119 .044 -.0575 18.35 .434 7 .15 7.51
6 135 43 .70 ,0026 .1136 3.25 .0121 .039 -.0746 15.13 .346 7.22 7.51









PpCO, ^HCOj PHCO, c HCO, ^H,CO, PH,CO, PK " a Cg
m M /L m m H g m M /L m l/m in m M /L m Eq/L •E q/m m ml/mm
1 2.077 23.35 36 51 .965 26.80 .106 1.11 1.53 4.25 7.56 22.15 5.21
2
3
2.654 29.03 39 45 1.454 27.50 .102 1.20 1 .53 4 .13 7 .90 16.25 3.69
4 27.15 28.27 70 35 24.99 27.21 4 .12 2.16 1.06 4 .03 24.50 110.00 27.30
5 29.30 27.82 78 35 26.89 26.78 3.72 2.41 1.04 4 .03 25.70 95.09 23.60
6 29.57 23.10 67 29 27.50 22.11 4 04 2 .07 .99 3 .80 26.90 87.43 23.01
7 28.30 22.53 67 30 26.23 21.70 4 .29 2 .07 .83 3.68 21.80 77.89 21.02
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Experiment 3 
The data presented In Table 5 represent results 
from an experiment designed to show the effects of the acute 
administration of mecamylamine on potassium excretion during 
isotonic NaCl infusion.
Two control periods (periods 1 and 2) were estab­
lished prior to the infusion of mecamylamine. The changes 
noted after mecamylamine administration were a fourfold in­
crease in potassium clearance, increase in urinary total COg, 
urinary bicarbonate * clearance of bicarbonate (Cg^g-) >
urinary volume and pH. These changes closely resembled re­
sults from earlier experiments in which the carbonic anhy- 
drase inhibitor, acetazolamide (Diamox^) was administered.
These data are therefore suggestive of a carbonic 
anhydrase inhibitor action of mecamylamine. Unexplainable 





















m g/rol m g/m in m l/m in
uM
m g/m l m g/m in m g/m in
c U u
ml/mh I
500 ml. H-0 P.O.
30 mg/kg. sodium pentobarbital I.V.
Prime I: 20 ml. 6% creatinine + 2.5 mg/kg. mecamylamine I.V.






































































Period T̂CO, •Vco, ‘pco. ĤCOJ PHCOJ c Hco; "H,co, PH , 0 0 , I'm
m M /L m m H g m M /L m l/m ln m M /L m Eq/L «Eq/m m m l/m m
1 180.92 76.90 172 108 175.60 73.65 28.84 5.32 3.25 3.19 12.50 150.00 47.022 174.91 77.04 148 107 170.34 73.82 29.54 4.57 3.22 3.18 13.10 167.68 52.733 188.00 79.18 149 109 183.40 75.90 27.56 4.60 3.28 3.10 13.20 150.48 48.54
4 207.91 90.30 154 117 203.15 86.78 28.09 4.76 3.52 4.15 16.60 199.20 48.005 215.88 89.73 160 112 210.94 86.36 25.29 4.94 3.37 4.26 17.80 184.23 43.256 224.41 92.57 204 110 218.11 89.26 31.42 6.30 3.31 4.41 18.90 243.05 55.11
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Experiment 4
Earlier experiments had shown that net tubular re­
absorption of mecamylamine occurred when the urine was al- 
tcalinized. The experiment represented by the data presented 
in Table 6 was designed to study the effects of the adminis­
tration of potassium chloride on mecamylamine excretion dur­
ing metabolic alkalosis.
The control values in periods 1, 2 and 3 show tu­
bular reabsorption of mecamylamine, with the clearance ra­
tios for mecamylamine to creatinine clearance (C^/CQp) of 
less than one. Urinary pH was well within the alkaline 
ranges. The potassium clearance indicated active tubular 
secretion of potassium as the clearance of potassium was 
higher than the simultaneously measured clearance of cre­
atinine.
Following potassium chloride infusion (periods 4, 5 
and 6) the clearance of mecamylamine (0%) continued to de­
crease. The amount of mecamylamine reabsorbed increased 
25$ and the was reduced further. Urine volume and
urine pH remained constant. Potassium clearance continued 
to indicate active tubular secretion of potassium.
The results from this experiment indicate further 
evidence of potassium and mecamylamine participation in a 
cation exchange system. Potassium loading resulted in in­
creased mecamylamine reabsorption with no change in urinary
37
pH. This effect is difficult to explain with the concept 
of excretion by filtration and non-ionic diffusion.
TABLE 7
EFFECTS OF ISGAMnAHlHE ADHXMISTBATION ON POTASSIUM EXCRETION SDRZNG ACDTB WTABOUC ACIDOSIS
Period Time u Kf UmV-Cc,P u.











500 ml. HgO P.O.
30 mg/kg. sodium pentobarbital I.V.
Prime I: 20 ml. 6% creatinine I.V.




Prime II: 8 mg/kg. mecamylamine in 20 ml. HgO







.0039 .1771 1.577 .264 .416 +.2389 106.67 2.35 5.27.0055 .1987 1.673 .447 .748 +.5493 136.00 3.76 5.28








*eriod • V c o , U p c o , ^ H c o ; PHCOJ C HCOJ
P
H,CO, Pk " n V
m M /L m m H g m M /L m l/m ln m M /L m Eq/L mBn/ttào ml/min
1 2.264 17.43 15.0 41 1.804 16.19 .668 .460 1.244 4 .35 29.03 17.42 4,00
2 .977 15.51 4 .5 37 .838 14.40 .349 .139 1.112 4 .38 32.83 19.70 4.50
3 1.043 13.09 3 .8 31 .927 12.16 .463 .116 .931 4 .38 37.70 22.88 5.22
4 .606 7.09 2 .5 26 .528 6 .46 .129 .078 .632 4 .43 40.90 64.50 14.56
5 .627 6.40 2 .7 27 .544 5 .59 .163 .083 .810 4 .88 41.94 70.17 14.40
6 .627 4 .23 2 .6 22 .546 3 .5 7 .300 .081 .660 5 .43 42.34 82.98 15.28
39
Experiment 5
The secretion of potassium has been shown to be 
minimal during metabolic acidosis, as the tubular sodium 
exchange is primarily with the hydrogen ion (Berliner et 
al., 1951). Data shown in Table 7 is from an experiment 
designed to show if the administration of mecamylamine 
would enhance potassium excretion during metabolic acidosis 
An isotonic NaCl solution was infused.
With the addition of mecamylamine to the infusion 
solution, there was a threefold increase in the clearance 
of potassium. Concurrently, urine flow doubled. Values 
for both urine and plasma HgCO^, pCOg, HCOg and total COg 
decreased from controls. These depressed urine and plasma 
COg and related values in periods 3» 4 and 5 are indicative 
of increased HCOg reabsorption with sustained metabolic 
acidosis.
The increase in potassium excretion following me­
camylamine administration was interpreted as further evi­
dence of a cation tubular exchange relationship between 
mecamylamine and potassium.
TABLE 8
EFFECTS OF KECAMTLAHXNE ADMINISTRATION ON POTASSIUM EXCRETION DURING ACUTE RESPIRATORY AUCALOSXS
Period Time Cr M u.M UmV-Cc,P cM upH %








500 ml. HgO P.O.
30 mg/kg. sodium pentobarbital I.V.
Prime I: 20 ml. 6% creatinine I.V.
Infusion I; .38% creatinine in .9% NaCI I.V. 8 5 ml/min. 
Hyperventilate 30 strokes/min. 275 cc/stroke
3 5.82 I .325 I
30.74 I I .207 I
Prime II: 8 mg/kg mecamylamine in 20 ml. HgO I.V.
Add 10 mg/kg/hr. mecamylamine to infusion
6 .10
6.15
4 75 41.17 .0036 .148 2.32 .154 .357 +.209 99.16 2.41 6.75
5 90 39.20 .0040 .156 2.32 .171 .398 +.242 99.50 2.54 6.80






o d "rco. "pco. "hcoj PHco; C Hco; "h,co. PH,CO. "k C K
m M /L nun Hg m M /L« m l/m in m M /L m E q /t #Eq/min m l/m in
1 .625 14.79 20 22 .025 14.13 .058 .600 .66 4.12 56.65 18.41 4.472 .566 14.40 17 22 .045 13.74 .062 .525 .66 4.07 92.84 19.22 4.72
4 3.85 11.90 23 18 3.14 11.36 .641 .712 .54 3.40 18.30 42.46 12.495 4.20 11.67 22 17 3.51 11.16 .732 .680 .51 3.25 18.40 42.69 13.146 4.20 11.56 24 15 3.46 11.11 .576 .740 .45 3.17 22.44 30.52 9.27
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Experiment 6
The results shown in Table 8 are from an experiment 
designed to indicate the effect of the acute administration 
of mecamylamine on potassium excretion during respiratory 
alkalosis. Mecamylamine was added to the infusion solution 
following the establishment of control values for potassium 
(periods 1 and 2).
In respiratory alkalosis ^Tqq *̂ ^HCO^ PpCOg are 
decreased. The renal tubular reaction to the increased al­
kalinity of the plasma is a decreased hydrOgôn ion secretion 
as a result of less COg available for hydration within the 
tubular cells. This decreased hydrogen ion secretion re­
sults in an increased secretion of potassium ions in ex­
change for the sodium ions which are continually being re­
absorbed (Elkington and Danowski, 1956). Therefore, if me­
camylamine secretion does inhibit potassium secretion, there 
should be evidence of this inhibition with mecamylamine in­
fusion.
The results of the mecamylamine infusion on potassium 
excretion showed no tubular inhibition of potassium, but 
rather potassium clearance increased threefold. (The in­
crease in potassium clearance could be as a result of the 
inhibition of potassium tubular reabsorption). Concurrently 
with the enhanced potassium clearance, there was seen an 
increased urine flow, an increased ^HCOg*
as well as an increased UpH.
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A control experiment vas conducted to determine the 
effects of respiratory alkalosis alone on the excretion of 
potassium. During the six periods, potassium clearance re­
mained relatively constant, although potassium concentra­
tion in the urine varied inversely with urine flow. There­
fore, the data from this experiment were interpreted as evi­
dence that mecamylamine administration enhanced potassium 
secretion. -
TABLE 9
BRBCrS or INCREASED PLASMA IgVElS OF HBCAMTLAMIMB ON POTASSIUM EXCRETION DURING HANNITOL DIURESIS









ml/min o g / n l m g/aàn I ml/min m g /m l mg/ann ml/min
500 «1. HnO P.O.
30 ag/kg. todlua peatobarbital I.V.
Prise I: 20 al. 6% ereatlniae I.V.






Priae II: 2.5 ag/kg. aecaaylnaine in 20 al. H-O I.V.







4 60 24.57 .0024 .0590 6.27 .0120 .0752 +.0162 31.35 1.28 6.80 7.40
5 70 23.60 .0024 .0566 6.49 .0114 .0740 +.0174 30.83 1.31 6.79 7.41
6 80 24.49 .0024 .0588 6.80 .0150 .1020 +.0432 42.50 1.74 6.7P 7.46
80 Priae I I I :  1.2 ag/kg. aecaaylnaine in 20 al. HoO I.V.
Add 10 ag/kg/hr. aecaajrlaaine to infusion
7 IIO 19.73 .0040 .0789 5.85 .033 .1931 +.II42 48.26 2.45 6.71 7.42
8 120 16.40 .0054 .0886 4.85 .042 .2037 + .II5 I 37.72 2.30 6.70 7.32
9 I  130 16.37 .0055 .0900 5.05 .044 .2222 +.1322 40.40 2.47 6.65
-f=-W
Period P°>r p̂co. "HCO; PHco; Chco; P Pk " u Ca
nmHg mM/L ml/min mM/t m B i/L ■Eq/min nd/min
48 13.00 20.07 4.27 2.16 1.44 4.60 6.05 39.93 8.68
41 12.27 19.60 4.25 2.22 1.23 4.65 6.35 43.13 9.29
44 12.03 20.64 4.32 2.25 1.32 4.60 6.85 50.69 11.10
11.23 2.26 4.50 6.50 40.76 9.06
34 10.80 20.37 3.45 2.22 1.02 4.65 6.70 43.48 9.35
10.69 2.22 4.68 7.05 47.94 10.24
9.62 2.38 4.30 6.35 37.15 8.64
33 9.01 16.06 2.72 2.26 .99 4.30 5.75 27.89 6.49
































This experiment (Table 9) and the following experi­
ment (Table 10) were conducted to assess the effect of In­
creased plasma levels of mecamylamlne on potassium excre­
tion during mannltol diuresis. Three control periods (l,
2 and 3) were followed by two additional experiment collec­
tion periods (4, 5 and 6;  J , 8 and 9) between which mecamy­
lamlne plasma levels were Increased.
The results' from the experiment presented In Table 9 
show that mecamylamlne Infusion had no significant effect on 
potassium excretion during periods 4, 5 and 6. During pe­
riods 7, 8 and 9, with the Increased plasma levels of meca­
mylamlne, potassium clearance was Inhibited 20^ from the 
previous experimental periods. This decrease In clearance 
occurred, however, with a concomitant decrease In the 
glomerular filtration rate (C^p)• Therefore, the amount of 
potassium reabsorbed (C^pPg - was calculated for the
nine periods. Reabsorption of potassium decreased by 12# 
when mecamylamlne was first Infused, and decreased by 40# 
upon further raising the plasma levels of mecamylamlne, 
from control values.
Data from this experiment, therefore, were Inter­
preted as evidence that mecamylamlne Inhibited the tubular 
reabsorption of potassium.
TABU 10
B IIB C rS  o r  nCBBASBD PLASMA ISVELS OF WCAHILAMDB OM lOTASSmi n C m m O M  lim iM B  MAmOXOL D i m s i s
Poiod Time Ccr 1, V "w UuV-CcP Cw % % C,AH
W/W. ««/■I wg/ain nd/rain mt/md mg/mim ml/mm
-125 500 ml. 8,0 P.O.
-105 30 mg/kg.tedium peatebarbital I.V,
- 60 Prime 1; 20 ml.' 6K ereatiaiae -t- .25 ml. 20% PA8, I.V.lafnoioa I: .38% ereatiaiae. .1% PAH ia 5% maaaitel, I.V. « S ml/mia.
1 10 33.16 7.10 6.67 7.30 104.35
2 20 34.44 8.07 6.65 7.36 120.66
3 30 34.78 8.60 6.64 7.35 96.28
30 Prime II: 3.0 mg/kg. mecanlamiae ia 20 ml. 8,0, I.V.Add 6 mg/kg/kr. meeamrlamiae te iafeaiea
4 65 37.83 .0021 .079 11.16 .0192 .214 +.135 102.03 2.70 6.69 7.29
5 75 .0023 9.25 .0212 .196 85.14 6.72 7.32 115.59
6 85 43.92 .0024 .105 14.41 .0224 .323 +.218 134.49 3.06 6.75 7.33
85 Prime III: 1.5 mg/kg meeamylemiae ia 20 ml. HgO, I.V.Add 12 mg/kg/fcr. mecaqrlamiae te iafaiiea
T 120 33.10 .0057 .189 10.21 .0508 .517 +.328 90.99 2.70 7.00 7.31 181.00
8 130 38.67 .0063 .244 12.00 .0588 .706 +.462 112.00 2.90 7.06 7.34 181.00
9 140 30.81 .0080 .256 9.11 .0684 .623 +.367 77.89 2.52 7.02 7.30 178.00
-»r
V J »
Paiad ^ T O O , ’’ t o o . ’’ h o o ; “ h , o o . PH ,0 0 , P. " a U^V Cc
a U /L Hr mM /L m l/m i. m U /L -%A •®l/m m m l/m i.
1 9.14 21.87 63 44 7.19 20.57 2.48 1.95 1.30 4.50 7.10 50.41 11.20
2 8.46 21.53 60 38 6.61 20.39 2.62 1.85 1.14 4.35 7.30 58.91 13.543 8.34 21.19 60 39 6.49 20.00 2.79 1.85 1.19 4.35 8.10 69.66 16.01
4 11.05 21.36 61 44 9.16 20.02 5.11 1.89 1.34 4.56 10.60 118.30 25.945 11.55 20.92 72 41 9.32 19.68 4.38 2.23 1.24 4.18 11.35 104.99 25.176 11.78 70 9.62 2.16 4.23 12.25 176.52 41.78
7 13.82 60 11.97 1.85 5.33 15.55 158.77 29.788 14.72 19.69 57 37 12.96 18.60 8.36 1.76 1.09 5.339 15.18 19.80 63 40 13.23 18.80 6.41 1.95 1.00 5.75 16.65 151.68 26.38
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Experiment 8
As vas described In the previous experiment, Table 
10 also Indicates the effects of Increased mecamylamlne 
plasma levels on potassium excretion during mannltol diure­
sis. The clearance of para-amino hlppura te (Cp^) as a mea­
sure of renal plasma flow vas Included In this and all sub­
sequent experiments.
The results In this experiment shov that, after the 
addition of mecamylamlne to the Infusion solution, potassium 
clearance (Cg) Increased 70$ over control values and Increased 
10$ further vhen plasma levels of mecamylamlne vere raised. 
This change In potassium excretion occurred vlth no signifi­
cant change In the amount of potassium filtered.
The Infusion of a mannltol solution has been shovn 
to result In a graded Increase In the rate of the excretion 
of potassium and bicarbonate. Urine pH, , as veil as
urine flov also Increase. Although these changes are found 
to occur In these data and simultaneously vlth mecamylamlne 
administration, the change In potassium clearance from con­
trol values vas sharp and sudden, not graded.
The results from this experiment have been Inter­
preted as further evidence that mecamylamlne either Increases 
potassium secretion or Inhibits potassium reabsorption.
u
BflBOS OF W C U a U U B  AND KCl AEHIIIISIBAXIOR M  POUSSZW AID WCtnuimB KZCBXim nmTi nT— ..„







■i/M> »«/"l I ■»*/»*> ml/mb | a«/M I aA/Ui
500 ml. B.0 p. o.
30 mg/kg. aodiam peatobarbital I.V.
Prime I: 20 ml. QK ereatiaiae + .25 m|. 20% PAB I.V.




Prime II: 2.0 mg/kg. meeamlylamiae ia 20 ml. HgO I.V. 
Add 3.0 mg/kg/hr. meeaiylamiae to iafaaioa
4 70 42.14 .0016 .0674 6.70 .0254 .1702 +.1028 106.37 2.52 6.635 80 44.30 .0019 .0842 7.10 .0304 .2158 +.1316 113.57 2.56 6.616 90 46.55 .0020 .0931 7.48 .0332 .2483 +.1552 124.15 2.67 6.6990 Add XCl to iafaiiea to gin .05 N KCl





















>V*>. "a Ca Ph. "n. "H.V
b M A ■Hi mW/L «a' A -BqA ml/mim mlS|A . à /m t .
1 21.03 22.42 120 34 17.32 21.40 3.16 3.71 1.02 3.95 7.40 29.19 7.39 104 20.4 80.46 .772 19.89 21.74 98 33 16.86 20.75 3.82 3.08 .99 3.95 6.05 28.44 7.20 105 12.6 57.96 .553 19.12 21.51 118 33 15.47 20.58 3.36 3.65 .99 3.95 4.95 22.13 5.60 102 10.0 44.70 .44
4 18.66 21.96 138 35 14.40 20.91 4.62 4.26 1.05 4.10 5.80 38.86 9.48 104 24.0 160.80 1.555 19.00 22.93 145 36 14.52 21.85 4.72 4.48 1.08 4.00 5.60 41.18 10.30 101 23.9 169.69 1.686 19.12 22.63 127 34 15.20 22.61 5.04 3.92 1.02 4.40 15.60 41.89 9.50 100 21.5 160.82 1.60
7 19.80 22.40 138 42 15.54 21.14 5.66 4.26 1.26 5.80 12.60 97.02 16.73 17.6 135.528 20.03 22.06 153 42 15.31 20.80 6.23 4.72 1.26 6.20 15.70 132.98 21.45 100 16.0 135.52 1.359 20.48 21.37 157 35 15.63 21.32 6.88 4.85 1.05 6.65 19.60 184.24 27.71 97 14.5 136.30 1.41
48
Experiment 9
The data in Tables 11 and 12 represent results from 
experiments designed to assess the mutual effects of both 
mecamylamlne and potassium administration on potassium and 
mecamylamlne excretion during a mannltol diuresis. Table 
11 shows data on mecamylamlne-potassium excretion relation­
ships in the anesthetized dog. Table 12 shows these rela­
tionships in the unanesthetized dog. Sodium concentrations 
were determined in experiments 9 and 10 (Tables 11 and 12).
In Table 11, control values are indicated in peri­
ods 1, 2 and 3. Mecamylamlne was then added to the infusion 
solution. Following three collection periods (4, 5 and 6) 
potassium chloride was then included in the infusion mixture. 
The effects of potassium administration on mecamylamlne ex­
cretion are shown in periods 7, 8 and 9*
Mecamylamlne administration resulted in a 30JÈ in­
crease in the clearance of potassium and a threefold increase 
in sodium clearance. Total urinary COg and Ujjqq- did not 
change significantly. Urine flow rate changed from 4.5 
cc/min. to 7.0 cc/min. The clearance of PAH (Cp^g) was en­
hanced 30^f but creatinine clearance was not significantly 
changed.
Potassium loading prior to periods 7, 8 and 9 did 
not result in a depression of mecamylamlne clearance 
(except in period 7).
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The data from this experiment were Interpreted as 
further evidence that mecamylamlne excretion Is In part by 
non-lonlc diffusion, for the clearance Increased as the 
urinary flow rate Increased. Evidence for a tubular cation 
exchange relationship between sodium and mecamylamlne was 
Indicated with the threefold Increase In sodium clearance 
following mecamylamlne administration.
TABLE 12
ERBCIS or MCAMYTAMTHE AMD KCl AEMmSISAXICH OH FOIASSIDM AHD WCAMZUMIHB BSSBTiaH DDKIH6 MUBUOL DIDnSIS IH IBS nif«̂ f»ni»-pTT»n ggg




o d / a r i o  1  m g / W mg/wSn ad/taia m g /u i  I tai/wSn
Uk,V-Ĉ P
m g /a in
c./c. u p H V»
n l/m in  |
PAH
-"/-k
SCO «1. H,0 P . O .  IPrise 1: 20 al. b% ereatlaine + .25 ml. 20% PAH I.V.
iBfntiom I: .38% ereatiBlae, .1% PAH la 5% maaaltol I.V. • S ml/mia.
1 10 29.65 5.53 5.75 7.30 108.18
2 20 34.30 5.22 5.76 7.32 100.05
3 30 37.64 5.50 5.81 7.31 112.2030 Prime II: 3 mg/kg. mecamrlamiae ia 20 ml. 8,0 I.V.
Add 8 mg/kg/hr. mecamylamiae to iafaaioa
4 70 45.47 .0018 .0818 4.79 .0386 .1897 1 +.1079 105,39 2.31 6.25 7.34 112.91
5 80 42.32 .0020 .0846 6.11 .0404 .2468 1 +.1622 123.40 2.91 6.38 7.34 132.73
6 90 34.27 .0022 .0754 5.35 .0426 .2279 1 +.1525 103.50 3.02 6.45 7.34 114.64
90 Add KCl to iafaaioa (withoat meeaqrlamiae) to give .05 N KCl
7 130 36.68 1  .0015 .0536 7.11 .0272 .1934 1 +.1398 132.47 3.61 6.65 7.35 127.«
8 140 39.751 .0015 .0572 8.05 .0260 .2093 1 +.1521 145.35 3.65 6.65 7.36 143.75
Period
^ T O O , ‘*TO>, V PHC30J CHOOJ^ PH,CO, P, Cx Un. Un.V U n.
- M / t nm H g - M /L nl/m io m M/L -E q /L mEq/aàn ml/mm -E q /L ■Gq/min ml/mln
1 1.61 19.43 16 38 1.13 18.29 .34 .48 1.14 5.08 8.05 44.52 8.76 137.50 20.16 105.23 .77
2 1.26 18.97 12 36 .90 17.89 .23 .36 1.08 4.68 9.80 51.16 10.93 141.50 47.50 247.95 1.75
3 1.03 18.97 11 37 .70 17.86 .21 .33 1.11 4.60 12.30 67.65 14.71 135.00 67.00 368.50 2.73
4 3.45 20.12 47 36 2.04 19.04 .51 1.41 1.08 4.63 22.83 106.00 22.89 136.67 154.28 789,00 5.41
5 4.25 19.89 47 36 2.84 18.81 .92 1.41 1.08 4.63 20.20 123.42 26.57 135.00 235.61 1439.58 10.66
6 4.94 19.09 49 34 3.47 18.07 1.03 1.47 1.02 4.63 19.07 102.02 22.03 136.00 296.88 1588.31 11.68




As indicated in the previous experiment, data from 
Table 12 show mecamylamlne and potassium tubular relation­
ships in- the unanesthetized dog. Again, mannltol was used 
in the infusion solution. It should be noted that meca- 
mylamine was added to the infusion solution only during the 
equilibration period following the controls periods. Hence, 
in periods 7 and 8 mecamylamlne was not infused simultan­
eously with potassium.
The clearance of potassium increased 8o$ following 
mecamylamlne administration and sodium excretion was en­
hanced threefold. The urinary total COg, UpCOg, and
CgQQg increased as well. These changes were reflected by 
a urine pH increase.
The clearance of mecamylamlne increased 20$ follow­
ing potassium loading. However, the amount of mecamylamlne 
contributed by tubular secretion (Uĵ V - CgyP^) decreased 
10$. Thus the clearance change reflected the lowered plas­
ma levels of mecamylamlne in periods 7 and 8 rather than 
lack of potassium inhibition.
The results from this experiment were interpreted 
as additional evidence that mecamylamlne and potassium were 
involved in a cation exchange transport mechanism.
«BLE 13
Bfncxs OF DUSim AMD KCI AUOHISIUXIDH oh FOUSSIDH AHD DUSXIHB EXCHHUOH DOUHB WHHIIOL DIDIBSIS IH 1BB OHUBSUBTIZBD DOG'
Pmad Time Ce P. V "o Ud V-C^P„ C» c»/c* % C PAH
mb • d /m b mg/ml a g / w a ml/orfn "*/■< m f/mm ■*/-» mi/mm -
- 85 500 ml. HoO P.O.
- 30 Prime I: 20 ml. M  ereatieiee + .25 ml. 20% PAH I.V.
lafusiOB I: .38% ereatiaiae, .1%PAH ia 5% maaaitol I.V. • S ml/mia.
1 10 49.48 4.28 5.78 7.41 150.73
2 >0 51.12 4.85 5.72 7.42 158.15
3 30 53.25 5.40 5.76 7.41 164.35
30 Prime II 3.0 mg/kg. Darstiae ia 20 ml. H.0 I.V.
Add 4.0 mg/kg/kr. Darstiae to iafaaioa
4 70 53.62 .0050 .268 7.12 .070 .498 +.230 99.60 1.86 6.30 7.41 179.70
5 80 56.95 .0047 .268 8.06 .058 .467 +.199 99.36 1.74 6.42 7.40 193,82
6 90 54.55 .0043 .235 7.91 .054 .427 +.192 99.30 1 1.82 6.52 7.41 180.8090 Add KCl .05 N KCl
7 130 58.98 .0047 .277 9.52 .033 .314 +.037 66.81 1.13 6.78 7.42 203.25
8 140 59.37 .0043 .255 10.11 .032 .324 +.039 75.34 1.27 6.81 7.42 216.59
9 ISO 64.18 .0043 .302 11.03 .028 .309 +.007 65.74 1.02 6.83 7.42 230.05
Period T̂OO, Ĥoo; Phooj C hooî PH.OO. Pc "c U^V Ce
mM/L H» mM/L ml/m b mM/L ■%A ■ * |/m b td /m in
1 2.08 21.49 22 S3 1.40 20.50 .292 .68 .99 4.25 14.35 61.42 14.45
2 1.85 21.71 18 33 1.31 20.72 .306 .54 .99 4.43 13.15 63.78 14.40
3 2.08 21.83 21 34 1.43 20.81 .371 .65 1.02 4.35 14.00 75.60 17.38
4 6.20 23.90 77 37 3.82 22.79 1.19 2.38 1.11 4.23 8.50 60.52 14.31
5 4.83 22.06 50 34 3.28 21.04 1.26 1.55 1.02 4.40 8.50 68.51 15.57
6 5.97 22.64 57 35 4.18 21.59 1.52 1.79 1.05 4.48 8.30 65.65 14.65
7 9.19 21.71 51 33 7.61 20.72 3.50 1.58 .99 5.33 14.80 140.90 26.438 10.57 21.60 55 32 8.88 20.64 4.35 1.69 .96 5.50 17.60 177.94 32.35
9 11.49 21.71 58 33 9.67 20.72 5.15 1.82 .99 5.68 20.60 227.22 40.00
U1w
TABLE 14
BFRCI3 OF WCAHZUmBB AMD KCl ADHanSHUXIOM ON FOIASSIOM AND W C A M n A i m  mrnnrrn^ MmTm: isoiOHIC NaCl
Period Time
^ M C c ^ M V « M U m V - C c , P ^ ^ M C m / C .
ml/mia mg/ml mg/mln ml/min "* /m l ml/jmti m g/m i. ml/mb ml/mb
-185 500 I H-0 P . O .
-165 30 ag/kg. *odium peatobirbital I.V.
-120 Prime I: 20 ml. (fi ereatiaiae + .25 ml. 20% PAH I.V.
lafutloa I: .38% ereatiaiae, .1% PAB la .9% NaCl I.V. 0 5’ml/mla.
1 IS 29.58 3.76 6.83 7.32 92.002 30 32.89 3.53 6.82 7.31 104.093 45 32.52 3.40 6.79 7.32 101.1245 Prime II: 5 mg/kg. mecamylamlae la 20 ml. B«0 I.V.
Add 10 mg/kg/hr. meeamylamlae to lafualoa
4 85 29.33 .0043 .126 2.74 .128 .351 +.225 82.00 2.79 6.56 7.38 86.665 100 30.75 .0036 .111 3.17 .103 .328 +.217 91.11 2.95 6.63 7.37 81.776 115 29.67 .0037 .110 3.73 .098 .366 +.256 98.91 3.33 6.76 7.37 78.57115 Add KCl to lafualoa to give .05 N KCl
7 155 33.59 .0053 .178 4.95 .067 .431 +.253 81.32 2.42 1 6.82 7.42 00.828 170 35.38 .0057 .202 4.97 .068 .437 +.235 76.67 2.16 1 6.02 7.42 83.17
U14=-



















































































































































Experiment 12  
Data presented in Tables l4 and 15 are those from 
experiments designed to evaluate the excretion changes of 
mecamylamlne and potassium, and Darstlne and potassium vlth 
Isotonic NaCl as the Infusion medium.
The experiments vere designed as follovs: The Iso­
tonic NaCl solution vas Infused tvo hours prior to deter­
mination of control values (periods 1, 2 and 3) In order to 
establish stable urine flov rates (Wessen et a^., 1950). 
Hence, It vas Inferred that vlth the constant urine flov, 
any changes In values noted follovlng the administration of 
mecamylamlne, Darstlne and potassium vould more nearly re­
flect the true effects of these substances.
Mecamylamlne and potassium relationships are seen 
In Table 14. The administration of mecamylamlne resulted 
In a slight Increase In the clearance of potassium (8$).
This increase vas reflected In an enhanced potassium urinary 
concentration (UgV). Mecamylamlne loading also resulted In 
a 505̂  depression of sodium clearance. Urinary flov rate
vas depressed temporarily. Total urinary COg (Ur ) » urine ̂ 2
bicarbonate concentration and the clearance of bi­
carbonate (Cjjco") were depressed follovlng mecamylamlne In-
3
fusion.
When potassium chloride vas added to the Infusion 
mixture, the clearance of mecamylamlne decreased 20^. This
56
decrease occurred even In the presence of a 30$ Increase In 
urine flow.
Results from this experiment vere interpreted as 
further evidence of a cation exchange relationship between 
mecamylamine and potassium. The results also indicate that 
sodium, as well as potassium, may be involved with mecamyl- 
amine in the exchange system.
T H U  15
niKcis or iMism hd kci à a a x v a u a a m  <m roussoH hd dustdb E xcam m  douk isonnc rnmci diobsis
Pcrioc! Tnne Pd % V % % C,AH
-l/-h -l/mk -e/w W/w. mi/mim
-IBS 500 ml. 8gO P.O.
-165 30 mg/kg. «odln peatebarbital I.V.
-120 Prime I: 20 ml 6% ereatiaiae +.25 ml. 20%.PAB I.V.
iHfaslra I: .38% ereitimlu, .1% PAH la .9% NaCl 1.7. # 5 ml/mla.
1 IS 39.92 2.98 6.82 182.422 30 47.43 2.33 6.98 194.983 45 49.44 2.00 6.97 191.1845 Prime II: 4 mg/kg. Oantlae la 20 ml. 8,0 I.V
Add 5 mg/kg/kr. Daratlae to lafaelea
4 85 50.671 .0120 .608 3.77 .257 .969 +.361 80.74 1.59 6.74 7.40 174.27S 100 49.80 .0120 .598 4.20 .216 .907 +.309 75.60 1.52 6.70 7.41 169.586 115 51.581 .0125 .645 3.90 .230 .897 +.252 71.76 1.40 6.73 7.42 176.60115 re .05 N KCl
‘ 7 155 56.74 .0130 .738 4.04 .237 .957 +.219 73.65 1.30 6.86 7.40 199.008 170 51.00 .0133 .678 3.91 .233 .911 +.233 68.50 1.34 6.86 7.40 188.769 185 50.141 .0138 .692 3.97 .224 .889 +.197 64.44 1.29 6.86 7.41 197.49
Period
V •Voo, V , U hco, *’hcx>j ^H O O - pH .CO , "a S "n. «N.
mW/L H* bM/L ml/mim m U /L m S f/ l . i£|/Mn md/mim -B|A ■l/Ui
1 11.27 58 9.48 1.79 3.50 17.50 52.06 14.86 146,00 57.50 171.7 1.172 17.64 66 15.60 2.04 3.30 24.00 55.99 16.97 146.00 97.00 226.3 1.553 19.35 74 17.07 2.28 3.40 27.00 54.00 15.88 145.00 116.50 232.0 1.60
4 9.52 57 , 7.76 1.76 3.45 13.00 49.01 14.21 145.00 62.00 233.7 1.615 7.70 51 6.15 1.55 3.45 13.75 57.75 16.74 145.00 60.50 254.1 1.756 10.08 62 8.16 1.92 3.45 17.50 66.50 19.28 146.00 65.00 253.5 1.74




The excretion relationships of Darstlne and potas­
sium were investigated in Experiment 13> Table 15, during 
isotonic NaCl infusion. Control values were established 
in periods 1, 2 and 3*
After Darstlne had been added to the infusion so­
lution, the data in periods 4, 5 and 6 show that there was 
no apparent change in the clearance of potassium or sodium. 
However, the urine concentration of potassium (Û ) and so­
dium decreased by 40$. When the amount of sodium and
potassium reabsorbed was calculated, sodium reabsorption in­
creased 5-10^, while potassium reabsorption did not change 
significantly. Darstlne loading also resulted in a decrease 
in urine pH, urinary total COg ), UpCOg, and
UjjgQO * It should be noted that these changes parallel those 
seen after the administration of mecamylamlne in Experiment 
12 (Table 14).
The administration of potassium chloride resulted 
in a 5-10# reduction in Darstlne clearance. This effect of 
potassium was reflected in the change in Darstine/creatinine 
clearance ratio (Cjj/Cqj,) from 1.52 to 1.32.
The results from this experiment show evidence that 
(l) Darstlne tubular secretion is involved in the cation ex­
change system; (2) sodium and potassium both are the cations 
involved in the exchange system; (3) Darstlne and mecamyla- 
mine tubular secretion are related.
XABLE 16
snscts OF wcâMmiraŒ and kci AmraisnAiiOH oh foiassiuh ahd wcamzlamüib bzcbkiioh nmnK isotohic hbci dxobbsis h u h BBSpnuaoRr
Period Time ^M C»PM V »M Um V-Cc P, ^ M V C p A H
ml/mio m*/ml mg/min ml/mill mg/ml ml/mln mg/mfn ml/min ml/mfal
-125 50 ml. H-O P . O .
-105 30 ag/kg. lodlua peatobarbitil I.V.
- 60 Prlae [ ;  2 0  ml. 6% ereatlalao + .25 ml. PAH I.V.
lafutloa I: .38% ereatiaiae, .1% PAH la .9% NaCl I.V. • 5 ml/mla.
- 30 Byperveatllate 15 atrokea/ala., 250 cc/atroke room air
1 IS 36.23 4.12 5.94 7.44 110.66
2 25 37,21 4.90 5.93 7.44 111.513 35 38.45 4.80 5.94 7.45 120.7935 Prim# II: 5 mg/kg. meeamylamlae la 20 ml. HoO I.V.
Add 10 mg/kg/hr. meeamylamlae to lafualoa
4 80 31.86 .0029 .092 3.03 .093 .282 1 +.190 97.24 3.05 6.80 T.46 120.075 90 32.90 .0036 .118 4.22 .070 .295 1 +.177 81.94 2.49 6.87 7.46 127.026 100 32.17 .0034 .109 4.90 .068 .333 1 +.224 97.94 3.04 6.88 7.46 120.88100 Add KCl to lafutloa to give .05 N KCl
.7 140 4.29 6.83 7.458 150 31.07 .0057 .177 5.42 .077 .417 1 +.240 1 73.16 2.35 6.82 7.44 99.219 160 32.96 1 .0058 .191 5.79 .078 .452 I +.261 1 77,93 2.36 6.81 7.43 96.77
\ji
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The experimental procedure for the data presented 
in Tables l6 and 17 were identical. Respiratory alkalosis 
was instituted in dogs by hyperventilation at approximately 
the same time as the standard infusion solution of isotonic 
NaCl was started. This procedure resulted in the mainte­
nance of a relatively constant urine flow, and a constant 
plasma pCOg. Results from an experiment in which the ex­
cretion of mecamylamlne and potassium were compared under 
such conditions are shown in Table l6.
The administration of mecamylamlne after control 
values had been established resulted in a 50-100^ increase 
in potassium clearance, and a 20^ enhancement of sodium 
clearance. Paralleling the urinary potassium and sodium 
changes were the threefold increase in total urinary COg 
(Ut^O )» PCOg, CgQQg and HgCO^» Mecamylamlne load­
ing caused very similar effects in the experiments listed 
in Tables 5, 8, 10 and 12.
With the addition of potassium chloride to the in­
fusion solution a 205È reduction in mecamylamlne clearance 
is seen. This reduction occurred even in the presence of 
a 20^ increase in urinary flow while urine pH remained 
constant.
Results from this experiment were interpreted as 
further evidence that mecamylamlne participates in a po­
tassium exchange mechanism.
XABLE 17
Bincxs 07 DAISZIHB AHD KCl ADMIHISXBAXIOH OH TOIASSIOM AHD DABSTIHB EXCRETION DDRINB ISOIOHIC NaCl DIURESIS HUB msPTaaTnay aTgatnarn
Period Time Pd V " o L'd V-Cg,P C . % S ah
(pÀn ml/min ly/ml w f^ /a in ml/oOii mg/ml ml/min mg/min ml/min ml/min-125 50 «1 HoO P.O.
-105 30 ■g/kg. Radium peatobarbital I.V.
- 60 Prime I; 20 ml. 6% creatinine + .25 ml. PAH I.V.
lafualoa I; .38% ereatiaiae, .1% PAH la .9% NaCl I.V. # 5 ml/mla.
- 55 Hjrperreatllate 16 atrokea/mla. # 300 cc/atroke room air
1
1 15 56.00 .166 6.98 7.45 148.78
2 30 61.00 .317 7.09 7.46 155.77
3 45 52.01 .471 7.29 7.47 142.80
45 Prime II; 4 mg/kg. Daratlae la 20 NI. HoO I.V
Add S mg/kg/hr. Daratlae to lafualoa
4 90 52.87 .099 .523 .900 .864 .778 +.255 78.59 1.49 7.46 7.47 165.18
S 105 49.00 .010 .490 .722 1.194 .862 +.372 86.20 1,75 7.34 7.48 133.14
6 120 59,00 .010 .590 .680 1.371 .932 +.342 93.28 1.58 7.24 7.48 144.29
120 Add KCl to lafualoa to give .06 N KCl
7 165 61.51 .0105 .646 1.517 .694 1.053 +.407 100.29 1.63 7.25 7.49 162.32e ISO 59.38 .0107 .635 1.953 .574 1.121 +.486 104.77 1.76 7.14 7.49 148.96
9 195 57.69 .0108 .623 1.286 .470 1.074 +.451 99.44 1.72 7.03 7.50 176.00
o\
Period V ' t c o . V , V ^ H C O ; p HCOJ CHOOJ ^ H ,C O , p H,CO, P * U k Cg ‘ n . «NnV Ck.
mM/L mmHg mM/L ml/min mM/L mEq/L •Eq/msn ml/min mEq/L •E q/m ïi ml/min
1 5.63 20.02 21 28 5.00 19.18 .04 .63 .84 4.20 134.50 22.29 5.31 151.00 34.00 5.64 .04
2 9.88 19.80 30 28 8.95 18.96 .15 .93 .84 3.85 81.40 25.80 6.70 149.80 46.20 14.65 .09
3 14.17 20.02 27 27 13.34 19.21 .33 .83 .81 3.85 53.10 25.01 6.50 149.00 50.40 23.74 .16
4 31.20 19.80 42 27 29.90 18.99 1.42 1.30 .81 3.80 29.52 26.57 6.99 145.00 90.72 81.65 .56
S 21.72 19.20 88 25 20.55 18.45 .80 1.17 .75 3.80 35.42 25.57 6.73 146.00 59.29 42.81 .29
6 17.37 19.09 37 25 16.23 18.34 .60 1.14 .n 3.75 38.71 26.32 7.00 143.00 37,13 25.25 .18
7 17.87 18.27 38 24 16.70 17.55 1.44 1.17 .72 4.95 42.55 64.55 13.04 154.00 62.87 99.37 .628 13.98 17.69 37 23 12.84 17.00 1.46 1.14 .69 5.20 56.00 109.37 21.00 156.00 63.60 124.21 .809 11.61 17.23 32 22 10.63 16.57 1.46 .99 .66 5.35 68.75 157.16 29.38 154.00 68.13 155.75 1.01
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Experiment 15
The excretion of Darstlne and potassium was studied 
In Experiment 15 (Table 17) during respiratory alkalosis and 
Isotonic NaCl diuresis. The following changes from the simi­
lar experiment just described with mecamylamlne are to be 
noted: the urine flow Increased and the plasma pCOg de­
creased throughout the nine periods. Respiratory alkalosis 
Is evident from the plasma pH values of 7*^5-7*50, with the 
low plasma pCOg values (28-22 mmHg).
The administration of Darstlne following the estab­
lishment of control values resulted In an Increased sodium 
clearance (C^g^, Increased and Ujjĝ V. Concurrent with 
urine sodium changes, urine total CO^ ) * urine pCOg
(UpCOg), bicarbonate (UggQ-), and HgCOg Increased 50 - 100#. 
Very similar results were seen when mecamylamlne excretion 
was studied during respiratory alkalosis (Table 14). To be 
noted Is that although potassium clearance did not Increase 
significantly, the urinary concentration of potassium (Û ) 
decreased 50^. This Ug decrease resulted In a constant 
amount of potassium excreted (Uĵ V) concurrent with the In­
creased urine flow. The decrease In potassium concentration 
Is accepted as evidence that Darstlne does depress tubular 
secretion of potassium. This evidence Is all the more sig­
nificant In the presence of the respiratory alkalosis, when 
potassium excretion has been shown to Increase.
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With the addition of potassium chloride to the in­
fusion solution, no significant change vais seen in Darstlne 
clearance. However, the urinary concentration of Darstlne 
decreased 50$.
The results from this experiment shov evidence that 
(l) as Darstlne excretion did not shov net tubular reabsorp­
tion vhen the urine vas alkaline, as does the excretion of 
veak bases, the tubular secretion of Darstlne is not in part 
by non-ionic diffusion; (2) potassium and Darstlne are re­
lated in a tubular secretion cation exchange system.
TABLE 18
BIRCTS OF WCUgrUMHIB AND KCl A1UHI8TBATZ0N ON FOIASSIDM AMD IgCAMTlAMINE EZCNBIION DOBING ISOTONIC Mmd BTnroiTa arm — .mMar.
P e r i o d T i m e U . u pH PAH

















500 ml. HoO P.O.
30 mg/kg. todlsm pentobarbital I.V.
Prime I: 20 ml. 6% creatinine + .25 ml. PAB I.V.
Infnalon I: .38% creatinine, .1% PAH in .9% NaCl I.V. # 5 ml/mln.





1.172 1 6.59 7.18 198.28.870 6.63 7.18 225.63
1.265 6.81 •7.18 221.06
rrime xx: a mg/eg. mBcujxaaxno xu su au.








.0028 .200 1.180 .1385 .163 -.038 58.37 .814 6.82 7.19
.0033 .240 1.555 .1347 .209 -.031 63.47 .873 6.80 7.15
.0035 .262 1.789 .1294 .231 -.031 66.41 .887 6.79 7.11
.0036 .279 3.864 .1325 .512 +.233 142.10 1.830 6.85 7.09
.0040 .322 4.615 .1225 .565 +.243 141.32 1.754 6.82 7.10








^ T O O , "pOO. •’-e " h o „ PHOOJ CHCOJ ^ H . 0 0 , PH .0 0 , Ppk Upk Cpk
m M/L mmHg m M /L ml/mfal m M /L -*iA •Bl/mk -«/■* -®1A iÆ|/mfai ml/mia
1 9.33 28.54 74 72 7.04 26.38 .31 2.29 2.16 3.10 23.32 27.33 8.82 141.00 83.41 97.77 .692 9.45 28.88 70 73 7.29 26.68 .24 2.16 2.20 3.16 33.60 29.23 9.25 140.00 119.00 103.53 .733 14.28 28.65 75 73 11.97 26.45 .57 2.31 2.20 3.20 24.22 30.64 8.57 140.00 138.03 162.88 l;16
4 13.71 29.22 71 73 11.52 27.02 .50 2.19 2.20 3.60 27.34 32.26 8.96 137.00 143.14 168.77 1.235 17.67 29.44 95 80 14.74 27.04 .85 2.93 2.40 3.64 21.56 33.53 9.21 140.00 148.20 230.45 1.656 25.27 28.84 139 85 20.97 26.28 1.43 4.30 2.56 3.72 21.74 38.89 10.46 137.00 155.28 277.80 2.03
7 33.39 28.50 163 87 28.35 25.87 4.23 5.04 2.63 5.78 54.00 208.66 36.10 135.00 120.50 465.61 3.458 31.92 27.62 165 83 26.83 25.12 4.92 5.09 2.50 6.70 62.50 288.44 43.05 135.00 125.50 57̂ .18 4.299 29.10 27.85 154 71 24.34 25.71 5.13 4.76 2.14 7.60 63.60 341.52 44.95 135.00 127.50 688.47 5.10
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Experiment l6 
Mecamylamlne and potassium and Darstlne and potas­
sium excretion relationships with sustained respiratory 
acidosis during Isotonic NaCl diuresis are reported In Tables 
18 and 19. Respiratory acidosis was Induced very shortly 
following the start of the standard Infusion mixture.
Respiratory acidosis has been shown to ,cause sodium 
retention, decreased potassium excretion, Increased urine 
and plasma pCO^ and decreased urine and plasma pH. These 
experiments were designed to show (l) whether mecamylamlne 
or Darstlne further depressed the excretion of potassium 
or sodium or whether these compounds caused an Increase In 
potassium and sodium excretion, (2) whether potassium admin­
istration resulted In a depression of mecamylamlne clearance 
In the presence of a highly acid urine, (3) whether Darstlne 
clearance decreased with potassium loading or If the clear­
ance Increased In the presence of sustained systemic acidosis.
The data shown In Table 18 are results from an ex­
periment In which mecamylamlne and potassium excretion were 
compared. A systemic acidosis was apparent from the low 
plasma pH values (7.I8-7.O8) and the high plasma pOOg values 
(72-87 mm Hg).
Following the addition of mecamylamlne to the In­
fusion solution, no significant change Is noted In the clear­
ance of potassium. Sodium clearance was Increased IO-8O#.
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It Is seen that mecamylamlne clearance showed net tubular 
reabsorption, and this reabsorption Is reflected In the me- 
camylamlne/creatlnlne clearance ratios of less than
one. This reabsorption In an acid urine (pH 6.80) Is diffi­
cult to explain solely on the basis of excretion by filtra­
tion and non-lonlc diffusion. Mecamylamlne loading super­
imposed upon the respiratory acidosis resulted In a lOJé de­
crease In GPR (Cgp) . The clearance of PAH (Cp^) remained 
constant.
Following potassium chloride Infusion, mecamylamlne 
clearance Increased twofold. The urinary concentration of 
mecamylamlne decreased 5-20^. This decrease occurred con­
comitantly with a twofold to threefold Increase In urine 
flow, and with a constant urine pH.
As the clearance of mecamylamlne Increased concom­
itantly with an Increased urine flow and was not Inhibited 
by potassium administration, results from this experiment 
were Interpreted as further evidence of mecamylamlne tubular 
secretion by non-lonlc diffusion.
TABLE 19
B m c n  cat nABant àm> kci ASHmsiuxim cm roussmi tm  n u s m  bxcbtior nnine isoionc Raci oionsis «o b  EESpnuaoET Acmosis
Period Tue Po % V "o u„v-c^P S %
•à/mi. 1 -*/W “«/«" "»/•* ni/nia mf/téa W/mb w/w.
-110 500 ml. BM p.o
- 90 90 mg/kg. «edlmm paatébaxfeital I.V.
- 45 PtIm 1: 20 mi 6% ereatiaiae + .25 mi. PAB I.V.lafulM I: .38% eimtlalM, .1% PAB Im .9% NmCl I.V. # 5 ml/mla.
Amlmml braatfelag 10% OO2 la 90% O2
1 15 53.591 1.279 5.78 7.09 240.942 30 52.26 1.187 5.78 7.08 215.88
S 45 54.62 1.507 5.80 7.09 235.3645 Prlaell: 4 ag/kg. Dantiae la 20 mi. BgO I.V.Add 5 ag/kg/br. Darstiae te lafeslea
4 90 43.641 .0132 .576 1.381 .6375 .880 +.304 66.70 1.53 5.94 7.05 154.21
S 105 39.93 .0130 .519 1.320 .6424 .848 +.829 65.23 1.63 5.91 7.04 147.66
6 120 41.191 .0135 .556 1.311 .7012 .919 +.863 68.09 1.65 5.90 7.08 136.80
120 Add KQ td lafaaloa te give .06 M ICI
7 165
8 180 42.93 .0160 1  .687 2.971 .34101 1.013 +.326 63.311 1.47 6.08 j  7.01 153.67
9 195 42.32 1 .0165 1  .698 3.724 .2800 1.014 1 +.316 61.451 1.45 6.10 1 7.02 179.30
Pknod




S " m . C a .
■ M /L •% m U /L ml/mém mW/L ■ = 1 A *Eq/mio u i/aàn inEf/L • S i / - * - W Z - b
1 2.2 21.51 23 66 1.49 19.53 .098 .71 1.98 4.44 25.67 32.83 7.39 160.00 93.62 119.74 .752 2.2 21.85 23 69 1.49 19.78 .089 .71 2.07 4.49 28.83 34.22 7.62 159.00 90.67 107.63 .683 2.4 22.76 26 70 1.60 20.66 .109 .80 2.10 4.50 28.80 43.40 9.64 158.00 90.72 136.72 .87
4 1.9 22.08 25 74 1.13 19.85 .078 .77 2.23 4.90 25.16 34.75 7.09 158.00 83.30 115.04 .735 2.2 22.19 38 75 1.33 19.93 .088 .87 2.26 5.13 29.39 88.79 7.56 158.00 79.20 104.54 .666 2.5 22.16 31 77 1.54 19.85 .102 .96 2.31 5.25 29.70 38.94 7.42 156.00 72.60 95.18 .61
7
8 6.8 21.75 20 79 6.18 19.37 .958 .62 2.38 9.50 43.50 129.24 13.60 151.00 89.50 265.90 1.769 7.0 21.18 23 76 6.29 18.89 1.240 .71 2.29 10.25 45.50 169.44 16.53 156.00 98.00 364.95 2.34
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Experiment 17
The excretion relationships of Darstlne and potas­
sium during respiratory acidosis and isotonic NaCl infusion 
are reported in this experiment (Table 19)• Respiratory 
acidosis is evident from the plasma pH values (7.08-7.01) 
and the high plasma pCOg values (66-79 mm Hg).
The administration of Darstlne (periods 4, 5 and 6) 
resulted in no significant change in the clearance of potas­
sium or sodium. However, a 10-1^ reduction in the urinary 
concentration of sodium occurred, and the amount of both 
sodium and potassium reabsorbed decreased. These potassium 
and sodium changes occurred concurrently with a 20$ reduction 
in the GrPR (Cg^) and an 80$ reduction in the clearance of 
PAH (Op^). Mecamylamlne administration under similar ex­
perimental conditions has also been shown to depress the 
GPR (Table I8).
With the addition of potassium chloride to the in­
fusion mixture, a 5-10$ reduction in Darstlne clearance oc­
curred. This decrease was reflected in the change in the 
Darstine/creatinine clearance ratio (0^/0^^) from I.60 to 
1.46.
The results from this experiment show further evi­
dence of a tubular cation exchange relationship between 
Darstlne and potassium. Sodium could also be involved in 
the cation exchange with Darstlne.
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Blood Pressure and ECQ Records 
Systemic blood pressure determinations and ECG re­
cordings were consistently obtained in the clearance studies. 
These records were secured prior to the infusion of the 
standard solution, and during the control and experimental 
collection periods.
No significant change was noted on the ECG record­
ings following the addition of either mecamylamine or Dar- 
stine to the infusion solution. ECG changes characteristic 
of hyperkalemia were seen only in these experiments where 
plasma potassium concentrations approached 6.3 - 7>0 mEg/L. 
during the infusion of potassium chloride.
Mean blood pressure values were calculated from the 
polygraph records for the control periods and the experi­
mental periods. The change of mean blood pressure after the 
infusion of mecamylamine or Darstine from the control period 
was then expressed as a percentage change. This procedure 
was followed for the pressure change after the addition of 
potassium chloride; however, reference pressure values were 
those obtained during mecamylamine or Darstine infusion.
Pulse pressure changes were calculated in like manner. The 
results which indicate the average per cent change in mean 
blood pressure and pulse pressure are shown in Table 20.
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t a b l e 20
AVERAGE PER CENT {%) CHANGE IN MEAN SYSTEMIC BLOOD 
PRESSURE AND PULSE PRESSURE











Pulse Pressure no change
A significant decrease in systemic blood pressure 
and pulse pressure is noted with mecamylamine or Darstine 
infusion in the anesthetized animal. However, there was no 
correlation between the decrease in blood pressure, simul­
taneously measured glomerular filtration rates and PAH clear­
ances, and tubular excretion changes which occurred with me­
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FIG. 1. Concentration pattern developed for mecamylamine, potassium, 
sodium, PAH and creatinine during stop flow in the dog. Maximal PAH con­
centration indicates proximal segment of the nephron marked by dotted 
line A. Minimal sodium concentration indicates distal segment. Dotted 
line B indicates total volume of urine trapped within kidney during the 





A control atop-flow concentration pattern for me­
camylamine, sodium, potassium PAH and creatinine Is shown 
In Figure 1.
Interpretation of concentration pattern: In Figure
1, concentrations of test substances In free-flov samples 
are plotted to the left of the first break In the curve In­
dicated by and Ug. Concentrations In the stop-flow sam­
ples are plotted against the per cent total volume of fluid 
trapped within the tubules during the period of ureteral 
occlusion to the right of the first break. The second break 
at the right of the chart Indicates cessation of serial sam­
ple collection. The post-occluslon free-flow sample concen­
tration Is Indicated by U^.
The total volume of fluid within the kidney Is 
found by summing the stop-flow samples from tube 1 to that 
tube which contains 50$ of the maximum concentration of In- 
ulln (Pltts et al., 1958). This tube Is arbitrarily se­
lected as marking the glomerular end of the proximal tubule. 
Indicated by the dotted line B and the 100$ volume at the 
bottom of the chart.
Peak maximum concentration of PAH, Indicated by 
dotted line A, Is used to mark the proximal segment. Prox­
imal PAH secretion was demonstrated by Malvln and co-workers
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(1958) by the simultaneouB injection of the PAH and inulin 
one minute before the release of the clamp on the ureteral 
catheter. PAH appeared in stop-flow samples ahead of inulin 
and in high concentrations, indicating secretion from peri­
tubular blood to the tubule lumen. Inulin remained at the 
glomerulus. The area of this peak concentration of PAH ap­
pearing in late sample collections was designated proximal 
s egment.
The rise of PAH concentration from the early samples 
is interpreted as increased tubular secretion of PAH into 
the proximal lumen. The fall of the PAH concentration in­
dicates new filtrate entrance into the tubule.
The terminal part of the nephron is designated 
distal segment with no atten^t made to differentiate between 
distal convoluted .tubule and the collecting ducts. It has 
been shown that sodium concentrations consistently tend to 
decrease to their lowest values in this distal segment and 
then rise to pre-occlusion values (Malvin ^  1958).
Hence, stop-flow samples with minimal.sodium concentrations 
are used to mark the area of the distal segment.
Creatinine concentration changes reflect water move­
ment throughout the nephron.
The concentration pattern for potassium shows a far 
distal peak, followed by a concentration decrease which oc­
curs approximately in the area of minimal sodium concentra-
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tlon. This far distal peak represents a distal (or collect­
ing duct) secreting mechanism for potassium (Pitts et aj.., 
1958). The minimal concentration indicates reabsorption in 
this area. _ •
In Figure 1, 5 mg/kg/hr. mecamylamine was added to 
the standard infusion solution containing mannitol, NaCl, 
creatinine and PAH. 4 mg/kg. mecamylamine was added to the 
priming solution.
r--»ee-flow clearance determinations showed mecamy­
lamine secretion, both pre- and post-occlusion. The stop- 
flow pattern developed for mecamylamine shows a slight fall 
in sample concentration in the distal segment. There then 
occurs a step-wise rise to a peak concentration in the prox­
imal area followed by a step-wise decrease in concentration 
as the glomerulus is approached.
This pattern in the proximal segment closely resem­
bles the pattern seen for PAH, with the peak concentration 
occurring simultaneously with PAH and likewise showing a 
fall in concentration toward free-flow values, indicating 
dilution by the addition of new filtrate. This pattern 
strongly suggests increased secretion of mecamylamine into 
the proximal tubule.
The fall in concentration in the distal tubular area 
suggests reabsorption of the mecamylamine. However, as the 
first stop-flow sample concentrations are increased over 
free-flow concentrations, and Ug, the fall in concentra-
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tlon is not decisive evidence that tubular reabosorption is 
occurring.
No true secretory peak concentration for mecamy­
lamine is seen in the distal segment. This finding was 
surprising for Pitts and co-workers (1958), and Sullivan 
et al., (i960) had localized acidification in the nephron 
in the distal segment. Acidification is closely related 
to the cation exchange mechanism (Berliner ^  al., 1951)• 
The two tubular mechanisms hypothesized for mecamylamine 
secretion are non-ionic diffusion into an acid urine, and 
a cation exchange system. As the free-flow urine samples 
showed tubular secretion, peak concentrations for mecamyl­
















PIG. 2. Stop flov localization of mecamylamine secretion during 
metabolic acidosis. Secretion occurred In the proximal segment. U/Pg In­
dicates net movement of water out of the nephron. The proximal segment Is 
marked by maximal n/Pp.„/Q/Fn_ ratios, the distal segment Is marked by 




As mecamylamine has been shown to have a very high 
clearance rate when the urine was acidified, it was of in­
terest to further investigate localization of tubular se­
cretion under conditions of metabolic acidosis. Figure 2, 
therefore, is a stop-flow pattern developed for mecamylamine 
during metabolic acidosis.
The curves in Figure 2 are read as in Figure 1. 
However, the concentrations of test substances in the urine 
and plasma have been used to calculate the urine/plasma con­
centration ratios (U/P ratio) for each sample. These U/P 
ratios have been used to calculate the TJ/P ratio of test sub­
stance to the U/P ratio of creatinine. This U/P^ / U/Pq^ 
ratio therefore reflects concentrations corrected for water 
reabsorption throughout the nephron. A U/P^ / U/Pgp ratio 
for a substance greater than unity therefore indicates tu­
bular secretion; a U/P^ / U/Pgp ratio for a substance less 
than unity indicates tubular reabsorption. Active tubular 
reabaorption for the substance is indicated only if the 
urine to plasma concentration ratios are less than unity, 
prior to calculation of the U/P^ / U/Pgp ratio. Sodium can 
be shown very clearly to be reabsorbed by an active process 
in both stop-flow and clearance studies. It should be noted 
that the patterns along the nephron developed for potassium, 
sodium and PAH are identical to the pattern in Figure 1, 
where actual concentrations were plotted against per cent
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volume In urine.
In Figure 2, standard clearance determinations in 
the timed free-flow urine collections showed net tubular se­
cretion of mecamylamine. This secretion is reflected in the 
U/Pju / U/Pqj, ratio in ITg and U3 where these values ap­
proximate that of PAH.
The stop-flow pattern for mecamylamine closely re­
sembles that pattern seen in Figure 1. After an initial 
slight peak in the far distal tubule the curve falls slight­
ly toward the area of the proximal end of the distal segment 
and then rises in the proximal segment to show mecamylamine 
U/P/creatinine U/P ratios nearly twice that in free-flow 
samples. The curve for mecamylamine then appears to pla­
teau, and finally falls toward post-occlusion ratio values.
The mecamylamine curve is interpreted as follows;
The very slight peak in the far distal area could be an in­
dication of increased tubular secretion in this area. This 
secretion peak is, however, certainly not the sharp peak 
that has been observed for potassium in the distal segment. 
The slight dip in the curve may be indicative of tubular 
reabsorption; however, this dip could as well be interpreted 
as less secretion in this area, for U/P mecamylamine / U/P 
creatinine ratios are still well over one. The rise of the 
curve in the area of the proximal tubule and the fall toward 
free-flow ratios is again an indication of increased tubular 
secretion of mecamylamine in the proximal segment.
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The evidence for Increased tubular secretion of 
mecamylamine in the distal area was not conclusively shown 
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PIG. 3* Stop flow localization of mecamylamine reabaorption during 
metabolic alkalosis. Mecamylamine Is reabsorbed In the distal segment. 
Sodium bicarbonate was Included In the Infusion solution.
81
Figure 3
The reabsorption of mecamylamine has been shovn to 
occur In clearance studies when the urine was alkallnlzed 
with NaHCO^ (Chapter 3; Scribner et , 1959)* Figure 3 re­
presents a stop flow pattern designed to Investigate the 
localization of tubular reabsorption of mecamylamine.
NaHCOg added to the standard Infusion solution?
Mecamylamine concentration In the Infusion was 
6 mg/kg/hr. Sodium bicarbonate was an 8 ^ solution. A prime 
dose of 4 mg/kg mecamylamine was given.
The stop-flow pattern developed for mecamylamine Is 
read as In Figure 2. The U/P ratios of test substances to 
the U/P ratios of creatinine are plotted against the per 
cent volume of samples.
Free-flow clearance determinations showed tubular 
reabsorption of mecamylamine, with mecamylamine to creatinine 
ratios less than unity. This reabsorption Is reflected In 
the U/Pm / U/Pq p ratios In the free flow samples Ug and 
U3; these ratios are shown to be less than 1.00.
The stop-flow pattern of mecamylamine shows a con­
tinual fall In the curve In the distal segment co-lncldent 
with that fall seen for sodium. The mecamylamine curve 
then rises to show a peak In the proximal segment, followed 
by a slight fall toward the post-occluslon free-flow sample.
The continual decrease In U/P^ / U/P^p ratio In the 
distal segment Is evidence that tubular reabsorption of
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mecamylamine occurs in this area of the nephron.
Clearance determinations from free flow samples 
showed potassium/creatinine ratios greater than unity, in­
dicating active tubular secretion of potassium. A strong 
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a control stop-flow pattern for Darstine is seen 
in Figure 4. The graph is read as in Figures 2 and 3*
Clearance determinations from free-flow samples U-ĵ,
Ug and Ug showed that Darstine was excreted by tubular se­
cretion. The U/Pjĵ p / U/Pgp ratios in Ug and samples 
show values greater than one.
The Darstine stop-flow pattern closely resembles 
the pattern developed for PAH. There is little change in
the curve until the distal part of the proximal segment is
reached when the curve rises sharply to a peak in the prox­
imal segment. The curve declines toward the free-flow post­
occlusion sample.
This peak in / U/Pg^ ratio in the proximal
segment co-incident with the PAH is evidence of tubular se­
cretion of. Darstine in this segment of the nephron.
There is no indication that Darstine reabsorption 
occurs in the distal segment.
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Kidney Slice Studies
Darstine has been demonstrated by clearance studies 
to be actively secreted In both the dog and the chicken. 
Similarly, there Is evidence that the kidney slices of rab­
bit and dog will accumulate Darstine under the conditions 
described In Chapter 2. The data from experiments In this 
work Indicate that the kidneys of the rat will accumulate 
Darstine and also mecamylamine when suitably Incubated.
The results from data on the uptake of mecamylamine- 
and Darstine In the rat..kidney slice are shown In Tables 21 
and 22. Table 21 represents control studies on the two com­
pounds. In the experiments with Darstine, 0.2 cc of 80 m ^  
was added consistently to the standard phosphate buffer of 
each vessel; 0.2 cc of 40 mgSè mecamylamine was added to the 
medium In the accumulation studies of this agent.
TABLE 21
ACCUMULATION OP DARSTINE AND MECAMYLAMINE 
IN RAT KIDNEY SLICES
Number of
Determinations Mean S/M Ratio
Darstine 6 3.90 -t A t
5 5.62 + .42
5 4.53 + .42
Mecamylamine 5 3.22 +. .32
6 5.01 f .62
4 (dog kidney 7.04 + .90
cortex)
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Table 22 indicates the results when à known inhibitor 
of aerobic phosphorylation, 2, 4-dinitrophenol (DNP), was 
added to the medium simultaneously with the two bases.
TABLE 22
EFFECTS OP DNP ON DARSTINE AND MECAMYLAMINE
ACCUMMDLATION IN RAT KIDNEY SLICES
Mean S/M Ratio
Control DNP
Darstine 5.42 (3) 4.36 (3)
Mecamylamine 5.08 (3) 3.82 (3)
Oxygen consumption was measured for the slices in 
each vessel. Oxygen uptake did not differ measurably ex­
cept for a significant increase in those slices where DNP 
was- added to the medium.
CHAPTER IV 
DISCUSSION
The results from the clearance studies a) substan­
tiate the hypothesis that the tubular secretion of mecamyla­
mine occurs at least in part by a cation exchange mechanism,
b) strongly indicate that potassium is the cation involved 
in the exchange system, and c) provide further evidence that 
Darstine as well is related to this transport mechanism.
In seven of eight experiments the administration of 
potassium chloride resulted in a depression of mecamylamine 
excretion. In five of the seven experiments, during either 
mannitol or NaCl diuresis, the clearance of mecamylamine was 
depressed; in two of the experiments, the urinary concentra­
tion of mecamylamine decreased. Domer (i960) also showed an 
inhibition of mecamylamine clearance with KCl loading, but 
the inhibition occurred either in the presence of an increas­
ing urinary pH or decreasing urinary flow. His data might 
suggest that the potassium effect could have been secondary 
to reabsorption by non-ionic diffusion. In the experiments 
reported here, depression of mecamylamine excretion occurred 
with either no change, or with an increased urinary flow rate;
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urinary pH increased only slightly in two experiments, while 
in five no change was seen. Therefore, the depression of me­
camylamine excretion by potassium could not be explained on 
the basis of a passive non-ionic diffusion but must be an in­
hibition of an active tubular process.
In nine of ten experiments reported to show the ef­
fects of the acute administration of mecamylamine on potas­
sium excretion, either there was no change in the clearance 
of potassium, or the clearance increased twofold to threefold. 
In the tenth experiment the clearance of potassium decreased. 
This decrease occurred with a reduction in glomerular filtra­
tion rate. The urinary concentration of potassium, following 
mecamylamine loading, was depressed significantly in two of 
the ten experiments. In both of these experiments, urinary 
flow increased.
The acute administration of mecamylamine resulted 
in an increase in the clearance of sodium in four of five 
experiments in which sodium concentrations were determined. 
The results in the fifth experiment may be of some signifi­
cance. In this experiment, the experimental conditions were 
such that neither the urine flow nor the glomerular filtra­
tion rate decreased by more than 10#, yet the clearance of 
sodium and the urinary concentration of sodium decreased by 
33# following mecamylamine infusion.
Thus, although the data from the experiments pre­
sented show variable effects of mecamylamine loading, it is
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tentatively suggested that mecamylamine enhances potassium 
excretion, and depresses sodium excretion.
The clearance of Darstine was shown to be inhibited 
by KCl administration in three of the four experiments where 
Darstine-potassium excretion relationships were studied.
These results agree with the evidence presented by Kandel, 
(1956). In the fourth experiment, although Darstine clear­
ance was not depressed, the urinary concentration of Dar­
stine decreased 50#.
No significant change in the clearance of potassium 
was noted following the acute administration of Darstine in 
the four experiments. In two of these experiments, however, 
there was an dOfè reduction in urinary concentration of potas­
sium; the urine flow increased only 30 - 50#.
In the three experiments in which the excretion of 
sodium was studied simultaneously with the excretion of Dar­
stine, the infusion of Darstine resulted in a) an increase 
in the clearance of sodium, b) no significant change in the 
clearance of sodium, and'c) a reduction in the clearance.
The increase in sodium clearance following Darstine loading 
occurred during respiratory alkalosis. This condition in 
itself has been shown to cause increased sodium excretion. 
Conversely, the reduction in sodium clearance following 
Darstine administration occurred during respiratory acidosis, 
with a decreased glomerular filtration rate. Both condi-
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tions have been shown to cause a decrease In sodium excre­
tion.
Two facts are of importance in evaluating the re­
sults in that experiment where there was no change in the 
clearance of sodium following Darstine administration. First, 
the urinary concentration of sodium decreased 8o$ while glo­
merular filtration rate remained constant, and urine flow in­
creased. In the investigations of the effects of choline 
administration on urinary electrolyte excretion, Solomon et 
al., (i960) showed that the reabsorption of sodium was en­
hanced following choline administration. The evidence pre­
sented by these workers was based on decreased urinary sodium 
concentrations in experiments where the GFR remained constant 
or increased. The data also showed an increased excretion of 
sodium during diuresis in the presence of choline; however, 
the concentration of sodium in the urine remained depressed. 
Second, there was a marked similarity between the effects of 
Darstine administration on sodium excretion, and in the ef­
fects of mecamylamine administration on sodium excretion, 
(Tables 14 and 15)•
Thus, the results indicate that potassium chloride 
loading administration inhibits Darstine excretion and Dar­
stine administration enhances sodium reabsorption as well 
as potassium reabsorption.
Evidence which substantiates the hypothesis that
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mecamylamine aa well as Daratlne can participate in the cat­
ion exchange system operating within the renal tubule is 
briefly outlined.
1. The reabaorption of sodium in the renal tubule 
is an active process.
2. At least part of the sodium from the lumen which 
is reabsorbed is exchanged for potassium or hydrogen from 
within the tubular cell.
3. Potassium and hydrogen compete for this exchange, 
this competition shown by a mutual reversable inhibition.
4. Mecamylamine and Darstine tubular secretion oc-, 
curs by active transport.
5. Potassium chloride administration inhibits the 
excretion of Darstine and mecamylamine. This inhibition is 
not related to other factors.
6. Darstine administration inhibits the excretion 
of both potassium and sodium.
7. Mecamylamine administration enhances the excre­
tion of potassium.
Although the effects on potassium excretion by Dar­
stine and mecamylamine administration are reversed, the ap­
parent inconsistency could be explained by relative affini­
ties for the transport system, i.e., potassium, Darstine 
and mecamylamine in decreasing order. Peters (i960) pre­
sented evidence that strong bases demonstrated this phenom-
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enon In relation to the "common" base secretory "system. 
Further, Domer (i960) has compared potassium excretion dur­
ing Darstine infusion before and after the force-feeding 
of Darstine. He found a decrease in potassium clearance; 
this would indicate some adaptive preference in the kidney 
for organic bases following the forced-feeding procedure.
The results of the stop-flow analyses on mecamyla­
mine excretion showed that the tubular secretion of mecamy­
lamine occurred in the proximal segment during both a control 
experiment and during metabolic acidosis. Reabsorption of 
mecamylamine occurred in the distal segment during metabolic 
alkalosis, when the urine was highly alkaline. These re­
sults from the stop-flow analyses demonstrate that mecamyla­
mine (and perhaps other organic bases) may be secreted in 
one part of the tubule-and be reabsorbed at another site. 
Jailer (1947) had speculated on the possibility that this 
process could indeed occur within the renal tubule. It is 
highly probable that these two processes of secretion at 
one site and reabsorption at another, can occur simultan­
eously. These studies do not eliminate a possible distal 
site for mecamylamine secretion.
The stop-flow studies showed that the tubular se­
cretion of Darstine occurred in the proximal tubule. No 
evidence either of increased tubular secretion or reab­
sorption in the distal tubule was apparent.
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Potassium tubular secretion has been shown to occur 
In the distal segment; reabsorption may occur In this seg­
ment as well as In the proximal segment (Sullivan and co­
workers, i960).
It Is therefore evident from the stop-flow studies 
that as a) the tubular secretion of potassium, Darstine and 
mecamylamine occur In different areas of the nephronjb) po­
tassium and mecamylamine exhibit a bl-directional flux*and
c) Darstine exhibits a uni-directional flux, and from the 
results of the clearance studies, a unifying theory for the 
excretion of these bases Is Impossible with available data.
There Is evidence from this work that suggests that 
the tubular secretion of mecamylamine as well as Darstine 
could occur In part by the generally accepted organic base 
transport system. Briefly, this evidence Is a) proximal 
tubular secretion of mecamylamine, b) the accumulation of 
mecamylamine In rat and dog kidney slices to show S/m ratios 
greater than one^and c) the Inhibition of this uptake by 2, 
4-dlnltrophenol -(MfP). The proposal Is further substantiated 
from the data presented by Voile and co-workers which showed 
that the administration of mecamylamine Inhibits NMN tubular 
transport In the chicken.
CHAPTER V 
SUMMARY AND CONCLUSIONS
The renal excretion of two organic bases, mecamyla­
mine (inversine^), a secondary amine and ganglionic blocking 
drug, and mepiperphenidol (Darstine^), quarternary ammonium 
compound and cholinergic blocking drug were studied in the 
dog.
The excretion of mecamylamine has been shown to be 
primarily influenced by the pH of the urine. This evidence 
suggested the possibility that the tubular excretion of me­
camylamine could be in part by the exchange mechanism which 
transports potassium. To test this hypothesis, the excretion 
of mecamylamine, potassium and sodium was studied following 
the acute administration of both mecamylamine and potassium 
chloride. Urinary pH changes were accomplished by systemic 
acidosis or alkalosis.
The renal tubular excretion of Darstine has been 
shown to be by an active transport system, and to be influ­
enced by potassium chloride administration. It was,there­
fore, of interest to investigate the excretion of this quar­
ternary ammonium compound under the experimental procedures
94
95
used for Investigating the excretion of the secondary amine.
The classical clearance technique and the technique 
of localization of tubular activity by stop-flow analysis 
were used for the excretion studies in the intact animal.
The accumulation of the compounds in rat kidney slices was 
used to evaluate the renal tubular excretion ^  vitro.
The findings in this work are:
1. Potassium chloride loading inhibits the tubular 
secretion of mecamylamine and Darstine in the intact animal. 
There was evidence that Darstine inhibits the tubular secre­
tion of potassium. The inhibition of the compounds by po­
tassium is discussed in relation to the mutual secretion of 
the organic and inorganic cations via the tubular exchange 
system.
2. Mecamylamine and Darstine accumulate within the 
rat kidney slice from the medium. The accumulation of these 
compounds in the slice is inhibited by 2, 4-dinitrophenol 
(DNP). These results are discussed in relation to evidence 
for active tubular transport of the organic bases.
3. The tubular secretion of mecamylamine occurs
by non-ionic diffusion as well as by active transport. The 
tubular reabsorption of mecamylamine occurs by non-ionic 
diffusion, with no evidence of active transport.
4. Darstine excretion occurs by filtration and tu­
bular secretion, as other workers had shown. No evidence
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for Darstine reabsorption vas noted.
5» As judged by stop-flow studies, the tubular se­
cretion of both mecamylamine and Darstine occurs vlthln the 
proximal segment of the nephron.
6. The tubular reabsorption of mecamylamine after 
alkallnlzatlon of the urine occurs In the distal segment of 
the nephron.
The results of this work are Interpreted as evidence 
that a) the tubular secretion of mecamylamine and Darstine 
occurs In part by the transport system which Involves Inor­
ganic cation exchange, b) the tubular secretion of mecamyla­
mine occurs In part by the organic base mechanism which trans­
ports Darstine.
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